|
特拉華州
|
| |
13-1840497
|
|
|
(州或其他司法管轄區)
公司或組織) |
| |
(國税局僱主識別號)
|
|
|
Glenpointe Center East,3樓
300 Frank W.Burr Boulevard,Suite 21 Teaneck,新澤西州 (主要執行辦公室地址) |
| |
07666-6712
(郵政編碼) |
|
|
每一類的名稱
|
| |
交易符號
|
| |
每間交易所的註冊名稱
|
|
|
A類普通股,0.0001美元
每股面值 |
| |
PAHC
|
| |
納斯達克股票市場
|
|
| 大型加速濾波器 | | | ☐ | | | | | | 加速填報器 | | | | |
| 非加速報税器 | | | ☐ | | | | | | 小型報表公司 | | | ☐ | |
| 新興成長型公司 | | | ☐ | | | | | | | | | | |
| | |
頁
|
| |||
前瞻性陳述
|
| | | | 3 | | |
市場排名和其他行業數據
|
| | | | 4 | | |
商標、服務標記和商品名稱
|
| | | | 5 | | |
第一部分 | | ||||||
Item 1.
Business
|
| | | | 6 | | |
Item 1A.
Risk Factors
|
| | | | 25 | | |
Item 1B.
Unresolved Staff Comments
|
| | | | 50 | | |
Item 2.
Properties
|
| | | | 50 | | |
Item 3.
Legal Proceedings
|
| | | | 51 | | |
Item 4.
Mine Safety Disclosures
|
| | | | 51 | | |
第二部分 | | ||||||
Item 5.
登記人普通股、相關股東事項和股票證券發行人購買市場
|
| | | | 52 | | |
Item 6.
Selected Financial Data
|
| | | | 54 | | |
Item 7.
管理層對財務狀況和經營結果的討論和分析
|
| | | | 56 | | |
Item 7A.
關於市場風險的定量和定性披露
|
| | | | 78 | | |
Item 8.
財務報表及補充數據
|
| | | | 80 | | |
Item 9.
會計人員在會計和財務披露方面的變化和分歧
|
| | | | 119 | | |
Item 9A.
Controls and Procedures
|
| | | | 119 | | |
Item 9B.
Other Information
|
| | | | 120 | | |
第三部分 | | ||||||
Item 10.
董事、高管和公司治理
|
| | | | 121 | | |
Item 11.
Executive Compensation
|
| | | | 121 | | |
Item 12.
某些實益所有者的安全所有權和管理層及相關股東事宜
|
| | | | 121 | | |
Item 13.
某些關係和相關交易,以及董事獨立性
|
| | | | 121 | | |
Item 14.
主要會計費用和服務
|
| | | | 121 | | |
第四部分 | | ||||||
Item 15.
展品,財務報表明細表
|
| | | | 122 | | |
SIGNATURES
|
| | | | 123 | | |
| | |
分段
|
| |
變化
|
| |
佔總數的百分比
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
For the Year Ended June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |
2019/2018
|
| |
2018/2017
|
| |
2019
|
| |
2018
|
| |
2017
|
| ||||||||||||||||||||||||||||||||||||
| | |
(百萬美元)
|
| | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
動物健康
|
| | | $ | 532 | | | | | $ | 532 | | | | | $ | 498 | | | | | $ | 0 | | | | |
|
0%
|
| | | | $ | 34 | | | | |
|
7%
|
| | | |
|
64%
|
| | | |
|
65%
|
| | | |
|
65%
|
| |
礦質營養
|
| | | | 234 | | | | | | 235 | | | | | | 218 | | | | | | (1) | | | | |
|
(0)%
|
| | | | | 17 | | | | |
|
8%
|
| | | |
|
28%
|
| | | |
|
29%
|
| | | |
|
29%
|
| |
性能產品
|
| | | | 62 | | | | | | 53 | | | | | | 48 | | | | | | 9 | | | | |
|
17%
|
| | | | | 5 | | | | |
|
11%
|
| | | |
|
8%
|
| | | |
|
7%
|
| | | |
|
6%
|
| |
總計
|
| | | $ | 828 | | | | | $ | 820 | | | | | $ | 764 | | | | | $ | 8 | | | | |
|
1%
|
| | | | $ | 56 | | | | |
|
7%
|
| | | | |
| | |
種
|
| |
變化
|
| |
佔總數的百分比
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
For the Year Ended June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |
2019/2018
|
| |
2018/2017
|
| |
2019
|
| |
2018
|
| |
2017
|
| ||||||||||||||||||||||||||||||||||||
| | |
(百萬美元)
|
| | | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
家禽
|
| | | $ | 316 | | | | | $ | 321 | | | | | $ | 301 | | | | | $ | (5) | | | | |
|
(2)%
|
| | | | $ | 20 | | | | |
|
7%
|
| | | |
|
38%
|
| | | |
|
39%
|
| | | |
|
39%
|
| |
乳品
|
| | | | 170 | | | | | | 177 | | | | | | 157 | | | | | | (7) | | | | |
|
(4)%
|
| | | | | 20 | | | | |
|
13%
|
| | | |
|
21%
|
| | | |
|
22%
|
| | | |
|
21%
|
| |
黃牛
|
| | | | 88 | | | | | | 80 | | | | | | 76 | | | | | | 8 | | | | |
|
10%
|
| | | | | 4 | | | | |
|
5%
|
| | | |
|
11%
|
| | | |
|
10%
|
| | | |
|
10%
|
| |
豬
|
| | | | 101 | | | | | | 100 | | | | | | 93 | | | | | | 1 | | | | |
|
1%
|
| | | | | 7 | | | | |
|
8%
|
| | | |
|
12%
|
| | | |
|
12%
|
| | | |
|
12%
|
| |
其他(1) | | | | | 153 | | | | | | 142 | | | | | | 137 | | | | | | 11 | | | | |
|
8%
|
| | | | | 5 | | | | |
|
4%
|
| | | |
|
18%
|
| | | |
|
17%
|
| | | |
|
18%
|
| |
總計
|
| | | $ | 828 | | | | | $ | 820 | | | | | $ | 764 | | | | | $ | 8 | | | | |
|
1%
|
| | | | $ | 56 | | | | |
|
7%
|
| | | | | |||||||||||||||
|
| | |
區域(2)
|
| |
變化
|
| |
佔總數的百分比
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
For the Year Ended June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |
2019/2018
|
| |
2018/2017
|
| |
2019
|
| |
2018
|
| |
2017
|
| ||||||||||||||||||||||||||||||||||||
| | |
(百萬美元)
|
| | | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
美國
|
| | | $ | 481 | | | | | $ | 491 | | | | | $ | 484 | | | | | $ | (10) | | | | |
|
(2)%
|
| | | | $ | 7 | | | | |
|
1%
|
| | | |
|
58%
|
| | | |
|
60%
|
| | | |
|
63%
|
| |
拉丁美洲和加拿大
|
| | | | 152 | | | | | | 143 | | | | | | 113 | | | | | | 9 | | | | |
|
6%
|
| | | | | 30 | | | | |
|
27%
|
| | | |
|
18%
|
| | | |
|
17%
|
| | | |
|
15%
|
| |
歐洲、中東和非洲
|
| | | | 105 | | | | | | 110 | | | | | | 96 | | | | | | (5) | | | | |
|
(5)%
|
| | | | | 14 | | | | |
|
15%
|
| | | |
|
13%
|
| | | |
|
13%
|
| | | |
|
13%
|
| |
亞太
|
| | | | 90 | | | | | | 76 | | | | | | 71 | | | | | | 14 | | | | |
|
18%
|
| | | | | 5 | | | | |
|
7%
|
| | | |
|
11%
|
| | | |
|
9%
|
| | | |
|
9%
|
| |
總計
|
| | | $ | 828 | | | | | $ | 820 | | | | | $ | 764 | | | | | $ | 8 | | | | |
|
1%
|
| | | | $ | 56 | | | | |
|
7%
|
| | | | |
| | |
調整後的EBITDA(1)
|
| |
變化
|
| |
佔總數的百分比(2)
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
For the Year Ended June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |
2019/2018
|
| |
2018/2017
|
| |
2019
|
| |
2018
|
| |
2017
|
| ||||||||||||||||||||||||||||||||||||
| | |
(百萬美元)
|
| | | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
動物健康
|
| | | $ | 136 | | | | | $ | 142 | | | | | $ | 130 | | | | | $ | (6) | | | | |
|
(4)%
|
| | | | $ | 12 | | | | |
|
9%
|
| | | |
|
87%
|
| | | |
|
87%
|
| | | |
|
87%
|
| |
礦質營養
|
| | | | 16 | | | | | | 19 | | | | | | 17 | | | | | | (3) | | | | |
|
(15)%
|
| | | | | 1 | | | | |
|
7%
|
| | | |
|
10%
|
| | | |
|
11%
|
| | | |
|
12%
|
| |
性能產品
|
| | | | 5 | | | | | | 2 | | | | | | 2 | | | | | | 3 | | | | |
|
151%
|
| | | | | (0) | | | | |
|
(9)%
|
| | | |
|
3%
|
| | | |
|
1%
|
| | | |
|
1%
|
| |
公司
|
| | | | (38) | | | | | | (33) | | | | | | (30) | | | | | | (5) | | | | |
|
*
|
| | | | | (4) | | | | |
|
*
|
| | | | | |||||||||||||||
總計
|
| | | $ | 118 | | | | | $ | 129 | | | | | $ | 120 | | | | | $ | (11) | | | | |
|
(8)%
|
| | | | $ | 9 | | | | |
|
7%
|
| | | | |
| | |
可識別資產淨值
|
| |
變化
|
| |
佔總數的百分比
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
As of June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |
2019/2018
|
| |
2018/2017
|
| |
2019
|
| |
2018
|
| |
2017
|
| ||||||||||||||||||||||||||||||||||||
| | |
(百萬美元)
|
| | | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
動物健康
|
| | | $ | 509 | | | | | $ | 456 | | | | | $ | 442 | | | | | $ | 53 | | | | |
|
12%
|
| | | | $ | 14 | | | | |
|
3%
|
| | | |
|
70%
|
| | | |
|
68%
|
| | | |
|
71%
|
| |
礦質營養
|
| | | | 68 | | | | | | 70 | | | | | | 55 | | | | | | (2) | | | | |
|
(3)%
|
| | | | | 15 | | | | |
|
26%
|
| | | |
|
9%
|
| | | |
|
10%
|
| | | |
|
9%
|
| |
性能產品
|
| | | | 33 | | | | | | 24 | | | | | | 24 | | | | | | 9 | | | | |
|
37%
|
| | | | | 0 | | | | |
|
1%
|
| | | |
|
5%
|
| | | |
|
4%
|
| | | |
|
4%
|
| |
公司
|
| | | | 117 | | | | | | 122 | | | | | | 102 | | | | | | (5) | | | | |
|
(4)%
|
| | | | | 20 | | | | |
|
20%
|
| | | |
|
16%
|
| | | |
|
18%
|
| | | |
|
16%
|
| |
總計
|
| | | $ | 727 | | | | | $ | 672 | | | | | $ | 623 | | | | | $ | 54 | | | | |
|
8%
|
| | | | $ | 49 | | | | |
|
8%
|
| | | | | |||||||||||||||
|
| | |
產品組
|
| |
變化
|
| |
佔總數的百分比
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
For the Year Ended June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |
2019/2018
|
| |
2018/2017
|
| |
2019
|
| |
2018
|
| |
2017
|
| ||||||||||||||||||||||||||||||||||||
| | |
(百萬美元)
|
| | | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
MFA和其他
|
| | | $ | 350 | | | | | $ | 337 | | | | | $ | 321 | | | | | $ | 13 | | | | |
|
4%
|
| | | | $ | 16 | | | | |
|
5%
|
| | | |
|
66%
|
| | | |
|
63%
|
| | | |
|
65%
|
| |
營養專科
|
| | | | 113 | | | | | | 123 | | | | | | 111 | | | | | | (10) | | | | |
|
(8)%
|
| | | | | 12 | | | | |
|
11%
|
| | | |
|
21%
|
| | | |
|
23%
|
| | | |
|
22%
|
| |
疫苗
|
| | | | 68 | | | | | | 72 | | | | | | 65 | | | | | | (4) | | | | |
|
(5)%
|
| | | | | 7 | | | | |
|
11%
|
| | | |
|
13%
|
| | | |
|
14%
|
| | | |
|
13%
|
| |
動物健康
|
| | | $ | 532 | | | | | $ | 532 | | | | | $ | 498 | | | | | $ | (0) | | | | |
|
(0)%
|
| | | | $ | 34 | | | | |
|
7%
|
| | | | | |||||||||||||||
|
| | |
區域(1)
|
| |
變化
|
| |
佔總數的百分比
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
For the Years Ended June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |
2019/2018
|
| |
2018/2017
|
| |
2019
|
| |
2018
|
| |
2017
|
| ||||||||||||||||||||||||||||||||||||
| | |
(百萬美元)
|
| | | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
美國
|
| | | $ | 199 | | | | | $ | 220 | | | | | $ | 230 | | | | | $ | (21) | | | | |
|
(10)%
|
| | | | $ | (10) | | | | |
|
(4)%
|
| | | |
|
37%
|
| | | |
|
41%
|
| | | |
|
46%
|
| |
拉丁美洲和加拿大
|
| | | | 142 | | | | | | 129 | | | | | | 104 | | | | | | 13 | | | | |
|
10%
|
| | | | | 25 | | | | |
|
24%
|
| | | |
|
27%
|
| | | |
|
24%
|
| | | |
|
21%
|
| |
歐洲、中東和非洲
|
| | | | 103 | | | | | | 108 | | | | | | 93 | | | | | | (5) | | | | |
|
(5)%
|
| | | | | 15 | | | | |
|
16%
|
| | | |
|
19%
|
| | | |
|
20%
|
| | | |
|
19%
|
| |
亞太
|
| | | | 88 | | | | | | 75 | | | | | | 71 | | | | | | 13 | | | | |
|
17%
|
| | | | | 4 | | | | |
|
6%
|
| | | |
|
17%
|
| | | |
|
14%
|
| | | |
|
14%
|
| |
總計
|
| | | $ | 532 | | | | | $ | 532 | | | | | $ | 498 | | | | | $ | — | | | | |
|
0%
|
| | | | $ | 34 | | | | |
|
7%
|
| | | | |
產品
|
| |
有效成分
|
| |
市場進入
有效成分 |
| |
描述
|
|
Terramycin®/TM-50®/TM-100™ | | | 土黴素 | | |
1951
|
| | 抗菌有多種用途,適用於多種物種 | |
尼加拉瓜® | | | 尼加拉瓜 | | |
1954
|
| | 家禽抗球蟲 | |
氨丙啉 | | | 氨丙啉 | | |
1960
|
| | 家禽和牛用抗球蟲 | |
膨脹防護(BLOAT Guard®) | | | 聚草烯 | | |
1967
|
| | 牛的消腫治療 | |
Banminth® | | | 酒石酸吡喃酮 | | |
1972
|
| | 牲畜驅蟲劑 | |
Mecadox® | | | 卡巴多 | | |
1972
|
| | 豬抗菌控制沙門氏菌病和痢疾 | |
STAFAC®/Eskalin™/V-MAX® | | | 維吉尼亞黴素 | | |
1975
|
| | 用於預防和控制家禽、豬和牛的疾病的抗菌劑 | |
Coxistac™/Posistac™ | | | 鹽黴素 | | |
1979
|
| | 家禽牛豬抗球蟲 | |
Rumatel® | | | 酒石酸莫蘭特 | | |
1981
|
| | 牲畜驅蟲劑 | |
Cerditac™/CerdiMix™ | | | 奧西苯達唑 | | |
1982
|
| | 牲畜驅蟲劑 | |
產品
|
| |
有效成分
|
| |
市場進入
有效成分 |
| |
描述
|
|
Aviax® | | | 半硬膜黴素 | | |
1995
|
| | 家禽抗球蟲 | |
NEO-Terramycin®/NEO-TM™ | | | 土黴素+新黴素 | | |
1999
|
| | 兩種抗菌藥的組合,具有多種用途,適用於多種物種 | |
Aviax®Plus/Avi-Carb® | | | Semduramicin+尼加拉瓜 | | |
2010
|
| | 家禽抗球蟲 | |
產品
|
| |
市場
入口 |
| |
描述
|
|
AB20® | | |
1989
|
| | 提高飼料整體質量的天然流動劑 | |
Animate® | | |
1999
|
| | 在關鍵過渡期維持奶牛適當的血鈣水平 | |
Omnigen-AF® | | |
2004
|
| | 優化奶牛的免疫狀態 | |
Provia 6086™ | | |
2013
|
| | 所有類別牲畜的直接飼餵微生物(凝固性芽孢桿菌) | |
Magni-Phi® | | |
2015
|
| | 有助於提高免疫反應並可能改善家禽對營養物質的吸收和利用的專有混合物 | |
Cellerate酵母解決方案® | | |
2017
|
| | 所有類別牲畜的專有酵母培養產品,幫助改善消化健康 | |
Provia Prime™ | | |
2019
|
| | 4路組合直接飼餵微生物優化家禽腸道健康 | |
產品
|
| |
市場
入口 |
| |
描述
|
|
V.H.® | | |
1974
|
| | 預防家禽新城疫的活疫苗 | |
定製®疫苗 | | |
1982
|
| | 針對家禽、豬和牛的細菌性或病毒性疾病的自體疫苗 | |
MVP佐劑® | | |
1982
|
| | 增強疫苗免疫應答的獸用疫苗成分 | |
TAbic®M.B. | | |
2004
|
| | 預防家禽傳染性法氏囊病的活疫苗 | |
MJPRRS® | | |
2007
|
| | 預防豬繁殖與呼吸綜合徵(PRRS)的自體疫苗 | |
TAbic®IB VAR | | |
2009
|
| | 家禽傳染性支氣管炎變異體1株233A活疫苗的研究 | |
TAbic®IB VAR206 | | |
2010
|
| | 預防家禽傳染性支氣管炎變異體206活疫苗 | |
MB-1TM | | |
2017
|
| | 預防家禽傳染性法氏囊病的孵化活疫苗 | |
Phi-TechTM | | |
2019
|
| | 便攜式電子注射裝置,能夠管理和正確提供疫苗 | |
業務部門
|
| |
定位
|
| |
擁有/租賃
|
| |
大約。SQ。
鏡頭 |
| |
目的
|
|
動物健康 | | | 貝特·謝梅什(Beit Shemesh),以色列 | | | 擁有/土地租賃 | | |
78,000
|
| | 製造和研究 | |
動物健康 | | | 布拉甘卡·保利斯塔(Braganca Paulista),巴西 | | | 擁有 | | |
50,000
|
| | 製造和管理 | |
動物健康 | | | 阿根廷布宜諾斯艾利斯 | | | 擁有 | | |
43,000
|
| | 製造和管理 | |
動物健康 | | | 奇里科斯,伊利諾伊州 | | | 擁有 | | |
19,000
|
| | 製造業 | |
動物健康 | | | 科瓦利斯,俄勒岡州 | | | 擁有 | | |
5,000
|
| | 研究 | |
動物健康 | | | 瓜魯霍斯,巴西 | | | 擁有 | | |
1,294,000
|
| | 製造,銷售,預混,研究和行政 | |
動物健康 | | | Neot Hovav,以色列 | | | 擁有/土地租賃 | | |
140,000
|
| | 製造和研究 | |
礦質營養 | | | 內布拉斯加州奧馬哈 | | | 擁有 | | |
84,000
|
| | 製造業 | |
動物健康 | | | 內布拉斯加州奧馬哈 | | | 擁有 | | |
43,000
|
| | 製造、銷售和研究 | |
動物健康 | | | Petach Tikva,以色列 | | | 擁有 | | |
60,000
|
| | 製造業 | |
業務部門
|
| |
定位
|
| |
擁有/租賃
|
| |
大約。SQ。
鏡頭 |
| |
目的
|
|
動物健康與礦物質營養 | | | 昆西,伊利諾伊州 | | | 擁有 | | |
306,000
|
| | 製造、銷售、研究和管理 | |
性能產品 | | |
聖達菲温泉,加利福尼亞州
|
| | 擁有 | | |
108,000
|
| | 製造業 | |
動物健康 | | |
賓夕法尼亞州州立學院
|
| | 擁有 | | |
13,000
|
| | 研究 | |
動物健康 | | | 明尼蘇達州聖保羅 | | | 租賃 | | |
5,000
|
| | 研究 | |
公司 | | | Teaneck,新澤西州 | | | 租賃 | | |
50,000
|
| | 公司和行政 | |
For the Year Ended June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |
2016
|
| |
2015
|
| |||||||||||||||
| | |
(以千計,每股金額除外)
|
| |||||||||||||||||||||||||||
操作結果數據 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
淨銷售額
|
| | | $ | 827,995 | | | | | $ | 819,982 | | | | | $ | 764,281 | | | | | $ | 751,526 | | | | | $ | 748,591 | | |
銷售商品成本
|
| | | | 563,371 | | | | | | 553,103 | | | | | | 516,038 | | | | | | 512,494 | | | | | | 515,311 | | |
毛利
|
| | | | 264,624 | | | | | | 266,879 | | | | | | 248,243 | | | | | | 239,032 | | | | | | 233,280 | | |
銷售,一般和管理費用
|
| | | | 181,398 | | | | | | 167,953 | | | | | | 150,309 | | | | | | 153,288 | | | | | | 145,612 | | |
營業收入
|
| | | | 83,226 | | | | | | 98,926 | | | | | | 97,934 | | | | | | 85,744 | | | | | | 87,668 | | |
利息費用,淨額
|
| | | | 11,776 | | | | | | 11,910 | | | | | | 14,906 | | | | | | 16,592 | | | | | | 14,305 | | |
外幣(收益)損失,淨額
|
| | | | (55) | | | | | | (1,054) | | | | | | (113) | | | | | | (7,609) | | | | | | (5,400) | | |
清償債務損失
|
| | | | — | | | | | | — | | | | | | 2,598 | | | | | | — | | | | | | — | | |
所得税前收入
|
| | | | 71,505 | | | | | | 88,070 | | | | | | 80,543 | | | | | | 76,761 | | | | | | 78,763 | | |
為所得税準備(利益)
|
| | | | 16,792 | | | | | | 23,187 | | | | | | 15,928 | | | | | | (5,967) | | | | | | 18,483 | | |
淨收入
|
| | | $ | 54,713 | | | | | $ | 64,883 | | | | | $ | 64,615 | | | | | $ | 82,728 | | | | | $ | 60,280 | | |
每股淨收益 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
基本型
|
| | | $ | 1.35 | | | | | $ | 1.61 | | | | | $ | 1.63 | | | | | $ | 2.11 | | | | | $ | 1.55 | | |
稀釋
|
| | | $ | 1.35 | | | | | $ | 1.61 | | | | | $ | 1.61 | | | | | $ | 2.07 | | | | | $ | 1.51 | | |
加權平均已發行普通股 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
基本型
|
| | | | 40,412 | | | | | | 40,181 | | | | | | 39,524 | | | | | | 39,254 | | | | | | 38,969 | | |
稀釋
|
| | | | 40,523 | | | | | | 40,385 | | | | | | 40,042 | | | | | | 39,962 | | | | | | 39,815 | | |
每股股息
|
| | | $ | 0.46 | | | | | $ | 0.40 | | | | | $ | 0.40 | | | | | $ | 0.40 | | | | | $ | 0.40 | | |
其他財務數據 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
調整後的EBITDA(1)
|
| | | $ | 118,037 | | | | | $ | 128,958 | | | | | $ | 120,119 | | | | | $ | 114,060 | | | | | $ | 110,019 | | |
經營活動提供的現金(2)
|
| | | | 47,169 | | | | | | 70,008 | | | | | | 98,385 | | | | | | 37,218 | | | | | | 68,704 | | |
資本支出
|
| | | | 29,891 | | | | | | 18,548 | | | | | | 20,880 | | | | | | 36,352 | | | | | | 20,058 | | |
For the Year Ended June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |
2016
|
| |
2015
|
| |||||||||||||||
| | |
(千)
|
| |||||||||||||||||||||||||||
資產負債表數據 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
現金和現金等價物和短期投資
|
| | | $ | 81,573 | | | | | $ | 79,168 | | | | | $ | 56,083 | | | | | $ | 33,605 | | | | | $ | 29,216 | | |
營運資金(3)
|
| | | | 242,902 | | | | | | 205,651 | | | | | | 198,036 | | | | | | 203,356 | | | | | | 175,988 | | |
總資產
|
| | | | 726,671 | | | | | | 671,679 | | | | | | 623,397 | | | | | | 607,835 | | | | | | 490,250 | | |
債務總額(4)
|
| | | | 326,175 | | | | | | 312,381 | | | | | | 313,141 | | | | | | 350,172 | | | | | | 286,450 | | |
長期債務及其他負債
|
| | | | 356,429 | | | | | | 343,504 | | | | | | 356,444 | | | | | | 408,578 | | | | | | 349,185 | | |
股東權益總額
|
| | | | 216,015 | | | | | | 184,954 | | | | | | 151,157 | | | | | | 90,480 | | | | | | 29,628 | | |
For the Year Ended June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |
2016
|
| |
2015
|
| |||||||||||||||
| | |
(千)
|
| |||||||||||||||||||||||||||
淨收入
|
| | | $ | 54,713 | | | | | $ | 64,883 | | | | | $ | 64,615 | | | | | $ | 82,728 | | | | | $ | 60,280 | | |
另加: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
利息費用,淨額
|
| | | | 11,776 | | | | | | 11,910 | | | | | | 14,906 | | | | | | 16,592 | | | | | | 14,305 | | |
為所得税準備(利益)
|
| | | | 16,792 | | | | | | 23,187 | | | | | | 15,928 | | | | | | (5,967) | | | | | | 18,483 | | |
折舊攤銷
|
| | | | 27,564 | | | | | | 26,943 | | | | | | 26,001 | | | | | | 23,452 | | | | | | 21,604 | | |
EBITDA
|
| | | | 110,845 | | | | | | 126,923 | | | | | | 121,450 | | | | | | 116,805 | | | | | | 114,672 | | |
重組成本
|
| | | | 6,281 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
股票薪酬
|
| | | | 2,259 | | | | | | 334 | | | | | | — | | | | | | — | | | | | | — | | |
與收購相關的銷售商品成本
|
| | | | — | | | | | | 1,671 | | | | | | — | | | | | | 2,566 | | | | | | — | | |
與收購相關的應計補償
|
| | | | — | | | | | | 1,152 | | | | | | 1,680 | | | | | | 1,680 | | | | | | 747 | | |
與收購相關的交易成本
|
| | | | 213 | | | | | | 400 | | | | | | 1,274 | | | | | | 618 | | | | | | — | | |
與收購相關的其他,淨
|
| | | | — | | | | | | (468) | | | | | | (972) | | | | | | — | | | | | | — | | |
其他
|
| | | | (1,506) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
養老金結算成本
|
| | | | — | | | | | | — | | | | | | 1,702 | | | | | | — | | | | | | — | | |
保險結算收益
|
| | | | — | | | | | | — | | | | | | (7,500) | | | | | | — | | | | | | — | | |
外幣(收益)損失,淨額
|
| | | | (55) | | | | | | (1,054) | | | | | | (113) | | | | | | (7,609) | | | | | | (5,400) | | |
清償債務損失
|
| | | | — | | | | | | — | | | | | | 2,598 | | | | | | — | | | | | | — | | |
調整後EBITDA
|
| | | $ | 118,037 | | | | | $ | 128,958 | | | | | $ | 120,119 | | | | | $ | 114,060 | | | | | $ | 110,019 | | |
For the Year Ended June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |
2016
|
| |
2015
|
| |||||||||||||||
| | |
(千)
|
| |||||||||||||||||||||||||||
EBITDA
|
| | | $ | 110,845 | | | | | $ | 126,923 | | | | | $ | 121,450 | | | | | $ | 116,805 | | | | | $ | 114,672 | | |
調整數 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
重組成本
|
| | | | 6,281 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
股票薪酬
|
| | | | 2,259 | | | | | | 334 | | | | | | — | | | | | | — | | | | | | — | | |
與收購相關的銷售商品成本
|
| | | | — | | | | | | 1,671 | | | | | | — | | | | | | 2,566 | | | | | | — | | |
與收購相關的應計補償
|
| | | | — | | | | | | 1,152 | | | | | | 1,680 | | | | | | 1,680 | | | | | | 747 | | |
與收購相關的交易成本
|
| | | | 213 | | | | | | 400 | | | | | | 1,274 | | | | | | 618 | | | | | | — | | |
與收購相關的其他,淨
|
| | | | — | | | | | | (468) | | | | | | (972) | | | | | | — | | | | | | — | | |
其他
|
| | | | (1,506) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
養老金結算成本
|
| | | | — | | | | | | — | | | | | | 1,702 | | | | | | — | | | | | | — | | |
保險結算收益
|
| | | | — | | | | | | — | | | | | | (7,500) | | | | | | — | | | | | | — | | |
外幣(收益)損失,淨額
|
| | | | (55) | | | | | | (1,054) | | | | | | (113) | | | | | | (7,609) | | | | | | (5,400) | | |
清償債務損失
|
| | | | — | | | | | | — | | | | | | 2,598 | | | | | | — | | | | | | — | | |
已付利息
|
| | | | (12,250) | | | | | | (11,208) | | | | | | (14,600) | | | | | | (14,215) | | | | | | (12,912) | | |
繳納所得税
|
| | | | (16,215) | | | | | | (15,191) | | | | | | (14,762) | | | | | | (16,828) | | | | | | (10,780) | | |
營業資產和負債及其他項目的變化
|
| | | | (42,190) | | | | | | (32,151) | | | | | | 1,402 | | | | | | (45,181) | | | | | | (12,337) | | |
由/(用於)保險結算/(索賠)提供的現金
|
| | | | — | | | | | | — | | | | | | 7,500 | | | | | | — | | | | | | (5,286) | | |
用於收購相關交易成本的現金
|
| | | | (213) | | | | | | (400) | | | | | | (1,274) | | | | | | (618) | | | | | | — | | |
經營活動提供的淨現金
|
| | | $ | 47,169 | | | | | $ | 70,008 | | | | | $ | 98,385 | | | | | $ | 37,218 | | | | | $ | 68,704 | | |
| | | | | |
變化
|
| ||||||||||||||||||||||||||||||||||||
For the Year Ended June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |
2019/2018
|
| |
2018/2017
|
| |||||||||||||||||||||||||||
| | |
(以千計,每股除外)
|
| |||||||||||||||||||||||||||||||||||||||
淨銷售額
|
| | | $ | 827,995 | | | | | $ | 819,982 | | | | | $ | 764,281 | | | | | $ | 8,013 | | | | |
|
1%
|
| | | | $ | 55,701 | | | | |
|
7%
|
| |
毛利
|
| | | | 264,624 | | | | | | 266,879 | | | | | | 248,243 | | | | | | (2,255) | | | | |
|
(1)%
|
| | | | | 18,636 | | | | |
|
8%
|
| |
銷售,一般和管理費用
|
| | | | 181,398 | | | | | | 167,953 | | | | | | 150,309 | | | | | | 13,445 | | | | |
|
8%
|
| | | | | 17,644 | | | | |
|
12%
|
| |
營業收入
|
| | | | 83,226 | | | | | | 98,926 | | | | | | 97,934 | | | | | | (15,700) | | | | |
|
(16)%
|
| | | | | 992 | | | | |
|
1%
|
| |
利息費用,淨額
|
| | | | 11,776 | | | | | | 11,910 | | | | | | 14,906 | | | | | | (134) | | | | |
|
(1)%
|
| | | | | (2,996) | | | | |
|
(20)%
|
| |
外幣(收益)損失,
網 |
| | | | (55) | | | | | | (1,054) | | | | | | (113) | | | | | | 999 | | | | |
|
*
|
| | | | | (941) | | | | |
|
*
|
| |
清償債務損失
|
| | | | — | | | | | | — | | | | | | 2,598 | | | | | | — | | | | | | * | | | | | | (2,598) | | | | | | * | | |
所得税前收入
|
| | | | 71,505 | | | | | | 88,070 | | | | | | 80,543 | | | | | | (16,565) | | | | |
|
(19)%
|
| | | | | 7,527 | | | | |
|
9%
|
| |
所得税準備金
|
| | | | 16,792 | | | | | | 23,187 | | | | | | 15,928 | | | | | | (6,395) | | | | |
|
(28)%
|
| | | | | 7,259 | | | | |
|
46%
|
| |
淨收入
|
| | | $ | 54,713 | | | | | $ | 64,883 | | | | | $ | 64,615 | | | | | $ | (10,170) | | | | |
|
(16)%
|
| | | | $ | 268 | | | | |
|
0%
|
| |
每股淨收益 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
基本型
|
| | | $ | 1.35 | | | | | $ | 1.61 | | | | | $ | 1.63 | | | | | $ | (0.26) | | | | | | | | | | | $ | (0.02) | | | | | | | | |
稀釋
|
| | | $ | 1.35 | | | | | $ | 1.61 | | | | | $ | 1.61 | | | | | $ | (0.26) | | | | | | | | | | | $ | — | | | | | | | | |
加權平均股數
出類拔萃 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
基本型
|
| | | | 40,412 | | | | | | 40,181 | | | | | | 39,524 | | | | | | | | | | | | | | | | | | | | | | | | | | |
稀釋
|
| | | | 40,523 | | | | | | 40,385 | | | | | | 40,042 | | | | | | | | | | | | | | | | | | | | | | | | | | |
淨銷售額比率 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
毛利
|
| | | | 32.0% | | | | | | 32.5% | | | | | | 32.5% | | | | | | | | | | | | | | | | | | | | | | | | | | |
銷售,一般和管理費用
|
| | |
|
21.9%
|
| | | |
|
20.5%
|
| | | |
|
19.7%
|
| | | | | | | | | | | | | | | | | | | | | | | | | |
營業收入
|
| | | | 10.1% | | | | | | 12.1% | | | | | | 12.8% | | | | | | | | | | | | | | | | | | | | | | | | | | |
所得税前收入
|
| | | | 8.6% | | | | | | 10.7% | | | | | | 10.5% | | | | | | | | | | | | | | | | | | | | | | | | | | |
淨收入
|
| | | | 6.6% | | | | | | 7.9% | | | | | | 8.5% | | | | | | | | | | | | | | | | | | | | | | | | | | |
有效税率
|
| | | | 23.5% | | | | | | 26.3% | | | | | | 19.8% | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | |
變化
|
| ||||||||||||||||||||||||||||||||||||
For the Year Ended June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |
2019/2018
|
| |
2018/2017
|
| |||||||||||||||||||||||||||
| | |
(千)
|
| |||||||||||||||||||||||||||||||||||||||
Net sales | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
MFA和其他
|
| | | $ | 350,468 | | | | | $ | 336,666 | | | | | $ | 321,430 | | | | | $ | 13,802 | | | | |
|
4%
|
| | | | $ | 15,236 | | | | |
|
5%
|
| |
營養專科
|
| | | | 113,215 | | | | | | 122,978 | | | | | | 111,282 | | | | | | (9,763) | | | | |
|
(8)%
|
| | | | | 11,696 | | | | |
|
11%
|
| |
疫苗
|
| | | | 68,291 | | | | | | 72,083 | | | | | | 65,033 | | | | | | (3,792) | | | | |
|
(5)%
|
| | | | | 7,050 | | | | |
|
11%
|
| |
動物健康
|
| | | | 531,974 | | | | | | 531,727 | | | | | | 497,745 | | | | | | 247 | | | | |
|
0%
|
| | | | | 33,982 | | | | |
|
7%
|
| |
礦質營養
|
| | | | 233,782 | | | | | | 234,922 | | | | | | 218,298 | | | | | | (1,140) | | | | |
|
(0)%
|
| | | | | 16,624 | | | | |
|
8%
|
| |
性能產品
|
| | | | 62,239 | | | | | | 53,333 | | | | | | 48,238 | | | | | | 8,906 | | | | |
|
17%
|
| | | | | 5,095 | | | | |
|
11%
|
| |
總計
|
| | | $ | 827,995 | | | | | $ | 819,982 | | | | | $ | 764,281 | | | | | $ | 8,013 | | | | |
|
1%
|
| | | | $ | 55,701 | | | | |
|
7%
|
| |
調整的EBITDA | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
動物健康
|
| | | $ | 136,049 | | | | | $ | 141,914 | | | | | $ | 130,261 | | | | | $ | (5,865) | | | | |
|
(4)%
|
| | | | $ | 11,653 | | | | |
|
9%
|
| |
礦質營養
|
| | | | 15,712 | | | | | | 18,583 | | | | | | 17,426 | | | | | | (2,871) | | | | |
|
(15)%
|
| | | | | 1,157 | | | | |
|
7%
|
| |
性能產品
|
| | | | 4,728 | | | | | | 1,881 | | | | | | 2,057 | | | | | | 2,847 | | | | |
|
151%
|
| | | | | (176) | | | | |
|
(9)%
|
| |
公司
|
| | | | (38,452) | | | | | | (33,420) | | | | | | (29,625) | | | | | | (5,032) | | | | |
|
*
|
| | | | | (3,795) | | | | |
|
*
|
| |
總計
|
| | | $ | 118,037 | | | | | $ | 128,958 | | | | | $ | 120,119 | | | | | $ | (10,921) | | | | |
|
(8)%
|
| | | | $ | 8,839 | | | | |
|
7%
|
| |
調整後的EBITDA比率與部門淨銷售額之比
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
動物健康
|
| | | | 25.6% | | | | | | 26.7% | | | | | | 26.2% | | | | | | | | | | | | | | | | | | | | | | | | | | |
礦質營養
|
| | | | 6.7% | | | | | | 7.9% | | | | | | 8.0% | | | | | | | | | | | | | | | | | | | | | | | | | | |
性能產品
|
| | | | 7.6% | | | | | | 3.5% | | | | | | 4.3% | | | | | | | | | | | | | | | | | | | | | | | | | | |
公司(1)
|
| | |
|
(4.6)%
|
| | | |
|
(4.1)%
|
| | | |
|
(3.9)%
|
| | | | | | | | | | | | | | | | | | | | | | | | | |
總計(1)
|
| | |
|
14.3%
|
| | | |
|
15.7%
|
| | | |
|
15.7%
|
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | |
變化
|
| ||||||||||||||||||||||||||||||||||||
For the Year Ended June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |
2019/2018
|
| |
2018/2017
|
| |||||||||||||||||||||||||||
| | |
(千)
|
| |||||||||||||||||||||||||||||||||||||||
淨收入
|
| | | $ | 54,713 | | | | | $ | 64,883 | | | | | $ | 64,615 | | | | | $ | (10,170) | | | | |
|
(16)%
|
| | | | $ | 268 | | | | |
|
0%
|
| |
利息費用,淨額
|
| | | | 11,776 | | | | | | 11,910 | | | | | | 14,906 | | | | | | (134) | | | | |
|
(1)%
|
| | | | | (2,996) | | | | |
|
(20)%
|
| |
所得税準備金
|
| | | | 16,792 | | | | | | 23,187 | | | | | | 15,928 | | | | | | (6,395) | | | | |
|
(28)%
|
| | | | | 7,259 | | | | |
|
46%
|
| |
折舊攤銷
|
| | | | 27,564 | | | | | | 26,943 | | | | | | 26,001 | | | | | | 621 | | | | |
|
2%
|
| | | | | 942 | | | | |
|
4%
|
| |
EBITDA
|
| | | | 110,845 | | | | | | 126,923 | | | | | | 121,450 | | | | | | (16,078) | | | | |
|
(13)%
|
| | | | | 5,473 | | | | |
|
5%
|
| |
重組成本
|
| | | | 6,281 | | | | | | — | | | | | | — | | | | | | 6,281 | | | | |
|
*
|
| | | | | — | | | | |
|
*
|
| |
股票薪酬
|
| | | | 2,259 | | | | | | 334 | | | | | | — | | | | | | 1,925 | | | | |
|
576%
|
| | | | | 334 | | | | |
|
*
|
| |
與收購相關的銷售商品成本
|
| | | | — | | | | | | 1,671 | | | | | | — | | | | | | (1,671) | | | | |
|
*
|
| | | | | 1,671 | | | | |
|
*
|
| |
與收購相關的應計補償
|
| | | | — | | | | | | 1,152 | | | | | | 1,680 | | | | | | (1,152) | | | | |
|
*
|
| | | | | (528) | | | | |
|
(31)%
|
| |
與收購相關的交易成本
|
| | | | 213 | | | | | | 400 | | | | | | 1,274 | | | | | | (187) | | | | |
|
(47)%
|
| | | | | (874) | | | | |
|
(69)%
|
| |
與收購相關的其他,淨額(1)
|
| | | | — | | | | | | (468) | | | | | | (972) | | | | | | 468 | | | | |
|
*
|
| | | | | 504 | | | | |
|
*
|
| |
其他,淨
|
| | | | (1,506) | | | | | | — | | | | | | — | | | | | | (1,506) | | | | |
|
*
|
| | | | | — | | | | |
|
*
|
| |
養老金結算費用
|
| | | | — | | | | | | — | | | | | | 1,702 | | | | | | — | | | | |
|
*
|
| | | | | (1,702) | | | | |
|
*
|
| |
保險結算收益
|
| | | | — | | | | | | — | | | | | | (7,500) | | | | | | — | | | | |
|
*
|
| | | | | 7,500 | | | | |
|
*
|
| |
外幣(收益)損失,
網 |
| | | | (55) | | | | | | (1,054) | | | | | | (113) | | | | | | 999 | | | | |
|
*
|
| | | | | (941) | | | | |
|
*
|
| |
清償債務損失
|
| | | | — | | | | | | — | | | | | | 2,598 | | | | | | — | | | | |
|
*
|
| | | | | (2,598) | | | | |
|
*
|
| |
調整後EBITDA
|
| | | $ | 118,037 | | | | | $ | 128,958 | | | | | $ | 120,119 | | | | | $ | (10,921) | | | | |
|
(8)%
|
| | | | $ | 8,839 | | | | |
|
7%
|
| |
For the Year Ended June 30
|
| |
2019
|
| |
2018
|
| ||||||
| | |
(以千計,不包括百分比)
|
| |||||||||
所得税準備金
|
| | | $ | 16,792 | | | | | $ | 23,187 | | |
有效所得税税率
|
| | | | 23.5% | | | | | | 26.3% | | |
某些所得税項目 | | | | | | | | | | | | | |
從行使的員工股票期權中受益
|
| | | $ | (310) | | | | | $ | (3,773) | | |
強制使用費
|
| | | | (360) | | | | | | 403 | | |
國內遞延税金資產減少
|
| | | | — | | | | | | 2,289 | | |
減少國外遞延税金資產
|
| | | | — | | | | | | 1,156 | | |
承認聯邦和外國税收抵免
|
| | | | (1,417) | | | | | | (565) | | |
從累計的其他綜合收入重新分類
|
| | | | — | | | | | | 527 | | |
釋放未確認的税收優惠
|
| | | | (1,271) | | | | | | (994) | | |
總計
|
| | | $ | (3,358) | | | | | $ | (957) | | |
所得税準備金,不包括某些項目
|
| | | $ | 20,150 | | | | | $ | 24,144 | | |
有效所得税税率,不包括某些項目
|
| | | | 28.2% | | | | | | 27.4% | | |
For the Year Ended June 30
|
| |
2018
|
| |
2017
|
| ||||||
| | |
(以千計,不包括百分比)
|
| |||||||||
所得税準備金
|
| | | $ | 23,187 | | | | | $ | 15,928 | | |
有效所得税税率
|
| | |
|
26.3%
|
| | | |
|
19.8%
|
| |
某些所得税項目 | | | | | | | | | | | | | |
從行使的員工股票期權中受益。
|
| | | $ | (3,773) | | | | | $ | (3,096) | | |
強制使用費
|
| | | | 403 | | | | | | — | | |
國內遞延税金資產減少
|
| | | | 2,289 | | | | | | — | | |
減少國外遞延税金資產
|
| | | | 1,156 | | | | | | — | | |
承認外國税收抵免
|
| | | | (565) | | | | | | — | | |
從累計的其他綜合收入重新分類
|
| | | | 527 | | | | | | — | | |
釋放未確認的税收優惠
|
| | | | (994) | | | | | | (500) | | |
放行外國估價津貼
|
| | | | — | | | | | | (4,118) | | |
總計
|
| | | $ | (957) | | | | | $ | (7,714) | | |
所得税準備金,不包括某些項目
|
| | | $ | 24,144 | | | | | $ | 23,642 | | |
有效所得税税率,不包括某些項目
|
| | |
|
27.4%
|
| | | |
|
29.3%
|
| |
| | | | | |
變化
|
| ||||||||||||||||||||||||
For the Year Ended June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |
2019/2018
|
| |
2018/2017
|
| |||||||||||||||
| | |
(千)
|
| |||||||||||||||||||||||||||
提供的現金/(用於): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
經營活動
|
| | | $ | 47,169 | | | | | $ | 70,008 | | | | | $ | 98,385 | | | | | $ | (22,839) | | | | | $ | (28,377) | | |
投資活動
|
| | | | (14,133) | | | | | | (84,612) | | | | | | (21,942) | | | | | | 70,479 | | | | | | (62,670) | | |
融資活動
|
| | | | (4,107) | | | | | | (11,775) | | | | | | (53,738) | | | | | | 7,668 | | | | | | 41,963 | | |
匯率變動對現金及現金等價物的影響
|
| | | | (524) | | | | | | (536) | | | | | | (227) | | | | | | 12 | | | | | | (309) | | |
現金及現金等價物淨增加/(減少)
|
| | | $ | 28,405 | | | | | $ | (26,915) | | | | | $ | 22,478 | | | | | $ | 55,320 | | | | | $ | (49,393) | | |
| | | | | |
變化
|
| ||||||||||||||||||||||||
For the Year Ended June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |
2019/2018
|
| |
2018/2017
|
| |||||||||||||||
| | |
(千)
|
| |||||||||||||||||||||||||||
EBITDA
|
| | | $ | 110,845 | | | | | $ | 126,923 | | | | | $ | 121,450 | | | | | $ | (16,078) | | | | | $ | 5,473 | | |
調整數
|
| | | | | | |||||||||||||||||||||||||
重組成本
|
| | | | 6,281 | | | | | | — | | | | | | — | | | | | | 6,281 | | | | | | — | | |
股票薪酬
|
| | | | 2,259 | | | | | | 334 | | | | | | — | | | | | | 1,925 | | | | | | 334 | | |
與收購相關的銷售商品成本
|
| | | | — | | | | | | 1,671 | | | | | | — | | | | | | (1,671) | | | | | | 1,671 | | |
與收購相關的應計補償
|
| | | | — | | | | | | 1,152 | | | | | | 1,680 | | | | | | (1,152) | | | | | | (528) | | |
與收購相關的交易成本
|
| | | | 213 | | | | | | 400 | | | | | | 1,274 | | | | | | (187) | | | | | | (874) | | |
與收購相關的其他,淨
|
| | | | — | | | | | | (468) | | | | | | (972) | | | | | | 468 | | | | | | 504 | | |
其他,淨
|
| | | | (1,506) | | | | | | — | | | | | | — | | | | | | (1,506) | | | | | | — | | |
養老金結算成本
|
| | | | — | | | | | | — | | | | | | 1,702 | | | | | | — | | | | | | (1,702) | | |
保險結算收益
|
| | | | — | | | | | | — | | | | | | (7,500) | | | | | | — | | | | | | 7,500 | | |
外幣(收益)損失,淨額
|
| | | | (55) | | | | | | (1,054) | | | | | | (113) | | | | | | 999 | | | | | | (941) | | |
清償債務損失
|
| | | | — | | | | | | — | | | | | | 2,598 | | | | | | — | | | | | | (2,598) | | |
已付利息
|
| | | | (12,250) | | | | | | (11,208) | | | | | | (14,600) | | | | | | (1,042) | | | | | | 3,392 | | |
繳納所得税
|
| | | | (16,215) | | | | | | (15,191) | | | | | | (14,762) | | | | | | (1,024) | | | | | | (429) | | |
營業資產和負債及其他項目的變化
|
| | | | (42,190) | | | | | | (32,151) | | | | | | 1,402 | | | | | | (10,039) | | | | | | (33,553) | | |
保險結算提供的現金
|
| | | | — | | | | | | — | | | | | | 7,500 | | | | | | — | | | | | | (7,500) | | |
用於收購相關交易成本的現金
|
| | | | (213) | | | | | | (400) | | | | | | (1,274) | | | | | | 187 | | | | | | 874 | | |
經營活動提供的淨現金
|
| | | $ | 47,169 | | | | | $ | 70,008 | | | | | $ | 98,385 | | | | | $ | (22,839) | | | | | $ | (28,377) | | |
| | | | | |
變化
|
| ||||||||||||||||||||||||
As of June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |
2019/2018
|
| |
2018/2017
|
| |||||||||||||||
| | |
(以千計,比率除外)
|
| |||||||||||||||||||||||||||
現金和現金等價物和短期投資
|
| | | $ | 81,573 | | | | | $ | 79,168 | | | | | $ | 56,083 | | | | | $ | 2,405 | | | | | $ | 23,085 | | |
營運資金
|
| | | | 242,902 | | | | | | 205,651 | | | | | | 198,036 | | | | | | 37,251 | | | | | | 7,615 | | |
流動資產對流動負債的比率
|
| | | | 2.71:1 | | | | | | 2.57:1 | | | | | | 2.81:1 | | | | |
| | | | | |
變化
|
| ||||||||||||||||||||||||
As of June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |
2019/2018
|
| |
2018/2017
|
| |||||||||||||||
| | |
(千)
|
| |||||||||||||||||||||||||||
應收賬款-貿易
|
| | | $ | 159,022 | | | | | $ | 135,742 | | | | | $ | 125,847 | | | | | $ | 23,280 | | | | | $ | 9,895 | | |
DSO
|
| | | | 70 | | | | | | 58 | | | | | | 58 | | | | |
| | | | | |
變化
|
| ||||||||||||||||||||||||
As of June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |
2019/2018
|
| |
2018/2017
|
| |||||||||||||||
| | |
(千)
|
| |||||||||||||||||||||||||||
盤存
|
| | | $ | 198,322 | | | | | $ | 178,170 | | | | | $ | 161,233 | | | | | $ | 20,152 | | | | | $ | 16,937 | | |
| | |
年數
|
| | ||||||||||||||||||||||||||
| | |
在%1內
|
| |
超過1到3
|
| |
超過3至5
|
| |
超過5
|
| |
總計
|
| |||||||||||||||
| | |
(千)
|
| |||||||||||||||||||||||||||
長期債務(包括本期部分)
|
| | | $ | 12,540 | | | | | $ | 218,750 | | | | | $ | — | | | | | $ | — | | | | | $ | 231,290 | | |
循環信貸工具
|
| | | | — | | | | | | 96,000 | | | | | | — | | | | | | — | | | | | | 96,000 | | |
利息支付
|
| | | | 12,100 | | | | | | 22,261 | | | | | | | | | | | | — | | | | | | 34,361 | | |
租賃承諾
|
| | | | 5,815 | | | | | | 7,351 | | | | | | 2,309 | | | | | | 765 | | | | | | 16,240 | | |
與收購相關的注意事項
|
| | | | 70 | | | | | | 140 | | | | | | 140 | | | | | | 140 | | | | | | 490 | | |
其他
|
| | | | 1,990 | | | | | | 792 | | | | | | 198 | | | | | | — | | | | | | 2,980 | | |
合同義務總額
|
| | | $ | 32,515 | | | | | $ | 345,294 | | | | | $ | 2,647 | | | | | $ | 905 | | | | | $ | 381,361 | | |
| | |
宿舍
|
| |
年
|
| ||||||||||||||||||||||||
For the Periods Ended
|
| |
9月30日,
2018 |
| |
12月31日,
2018 |
| |
三月三十一號,
2019 |
| |
六月三十日
2019 |
| |
六月三十日
2019 |
| |||||||||||||||
| | |
(千)
|
| |||||||||||||||||||||||||||
淨銷售額 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
MFA和其他
|
| | | $ | 87,004 | | | | | $ | 93,054 | | | | | $ | 84,095 | | | | | $ | 86,315 | | | | | $ | 350,468 | | |
營養專科
|
| | | | 26,970 | | | | | | 29,460 | | | | | | 28,227 | | | | | | 28,558 | | | | | | 113,215 | | |
疫苗
|
| | | | 17,215 | | | | | | 17,048 | | | | | | 16,867 | | | | | | 17,161 | | | | | | 68,291 | | |
動物健康
|
| | | $ | 131,189 | | | | | $ | 139,562 | | | | | $ | 129,189 | | | | | $ | 132,034 | | | | | $ | 531,974 | | |
礦質營養
|
| | | | 54,838 | | | | | | 62,319 | | | | | | 60,653 | | | | | | 55,972 | | | | | | 233,782 | | |
性能產品
|
| | | | 14,126 | | | | | | 16,342 | | | | | | 15,894 | | | | | | 15,877 | | | | | | 62,239 | | |
總淨銷售額
|
| | | | 200,153 | | | | | | 218,223 | | | | | | 205,736 | | | | | | 203,883 | | | | | | 827,995 | | |
銷售商品成本
|
| | | | 134,348 | | | | | | 149,579 | | | | | | 140,864 | | | | | | 138,580 | | | | | | 563,371 | | |
毛利
|
| | | | 65,805 | | | | | | 68,644 | | | | | | 64,872 | | | | | | 65,303 | | | | | | 264,624 | | |
銷售,一般和管理費用
|
| | | | 42,952 | | | | | | 42,938 | | | | | | 42,304 | | | | | | 53,204 | | | | | | 181,398 | | |
營業收入
|
| | | | 22,853 | | | | | | 25,706 | | | | | | 22,568 | | | | | | 12,099 | | | | | | 83,226 | | |
利息費用,淨額
|
| | | | 2,783 | | | | | | 3,015 | | | | | | 2,931 | | | | | | 3,047 | | | | | | 11,776 | | |
外幣(收益)損失,淨額
|
| | | | (2,635) | | | | | | 2,617 | | | | | | 122 | | | | | | (159) | | | | | | (55) | | |
所得税前收入
|
| | | | 22,705 | | | | | | 20,074 | | | | | | 19,515 | | | | | | 9,211 | | | | | | 71,505 | | |
所得税準備金
|
| | | | 6,391 | | | | | | 5,326 | | | | | | 4,666 | | | | | | 409 | | | | | | 16,792 | | |
淨收入
|
| | | $ | 16,314 | | | | | $ | 14,748 | | | | | $ | 14,849 | | | | | $ | 8,802 | | | | | $ | 54,713 | | |
每股淨收益 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
基本型
|
| | | $ | 0.40 | | | | | $ | 0.37 | | | | | $ | 0.37 | | | | | $ | 0.22 | | | | | $ | 1.35 | | |
稀釋
|
| | | $ | 0.40 | | | | | $ | 0.36 | | | | | $ | 0.37 | | | | | $ | 0.22 | | | | | $ | 1.35 | | |
調整後EBITDA | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
動物健康
|
| | | $ | 35,716 | | | | | $ | 35,925 | | | | | $ | 33,241 | | | | | $ | 31,167 | | | | | $ | 136,049 | | |
礦質營養
|
| | | | 2,563 | | | | | | 4,084 | | | | | | 5,287 | | | | | | 3,778 | | | | | | 15,712 | | |
性能產品
|
| | | | 716 | | | | | | 1,514 | | | | | | 1,330 | | | | | | 1,168 | | | | | | 4,728 | | |
公司
|
| | | | (8,886) | | | | | | (9,918) | | | | | | (9,850) | | | | | | (9,798) | | | | | | (38,452) | | |
調整後EBITDA
|
| | | $ | 30,109 | | | | | $ | 31,605 | | | | | $ | 30,008 | | | | | $ | 26,315 | | | | | $ | 118,037 | | |
淨收益與調整後EBITDA的對賬
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
淨收入
|
| | | $ | 16,314 | | | | | $ | 14,748 | | | | | $ | 14,849 | | | | | $ | 8,802 | | | | | $ | 54,713 | | |
利息費用,淨額
|
| | | | 2,783 | | | | | | 3,015 | | | | | | 2,931 | | | | | | 3,047 | | | | | | 11,776 | | |
所得税準備金
|
| | | | 6,391 | | | | | | 5,326 | | | | | | 4,666 | | | | | | 409 | | | | | | 16,792 | | |
折舊攤銷
|
| | | | 6,691 | | | | | | 6,841 | | | | | | 6,875 | | | | | | 7,157 | | | | | | 27,564 | | |
EBITDA
|
| | | | 32,179 | | | | | | 29,930 | | | | | | 29,321 | | | | | | 19,415 | | | | | | 110,845 | | |
重組成本
|
| | | | — | | | | | | — | | | | | | — | | | | | | 6,281 | | | | | | 6,281 | | |
股票薪酬
|
| | | | 565 | | | | | | 564 | | | | | | 565 | | | | | | 565 | | | | | | 2,259 | | |
與收購相關的交易成本
|
| | | | — | | | | | | — | | | | | | — | | | | | | 213 | | | | | | 213 | | |
其他
|
| | | | — | | | | | | (1,506) | | | | | | — | | | | | | — | | | | | | (1,506) | | |
外幣(收益)損失,淨額
|
| | | | (2,635) | | | | | | 2,617 | | | | | | 122 | | | | | | (159) | | | | | | (55) | | |
調整後EBITDA
|
| | | $ | 30,109 | | | | | $ | 31,605 | | | | | $ | 30,008 | | | | | $ | 26,315 | | | | | $ | 118,037 | | |
| | |
宿舍
|
| |
年
|
| ||||||||||||||||||||||||
For the Periods Ended
|
| |
9月30日,
2017 |
| |
12月31日,
2017 |
| |
三月三十一號,
2018 |
| |
六月三十日
2018 |
| |
六月三十日
2018 |
| |||||||||||||||
| | |
(千)
|
| |||||||||||||||||||||||||||
淨銷售額 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
MFA和其他
|
| | | $ | 79,603 | | | | | $ | 82,018 | | | | | $ | 82,935 | | | | | $ | 92,110 | | | | | $ | 336,666 | | |
營養專科
|
| | | | 30,777 | | | | | | 32,623 | | | | | | 31,366 | | | | | | 28,212 | | | | | | 122,978 | | |
疫苗
|
| | | | 18,461 | | | | | | 18,204 | | | | | | 18,009 | | | | | | 17,409 | | | | | | 72,083 | | |
動物健康
|
| | | $ | 128,841 | | | | | $ | 132,845 | | | | | $ | 132,310 | | | | | $ | 137,731 | | | | | $ | 531,727 | | |
礦質營養
|
| | | | 52,073 | | | | | | 59,616 | | | | | | 62,938 | | | | | | 60,295 | | | | | | 234,922 | | |
性能產品
|
| | | | 12,498 | | | | | | 13,415 | | | | | | 13,660 | | | | | | 13,760 | | | | | | 53,333 | | |
總淨銷售額
|
| | | | 193,412 | | | | | | 205,876 | | | | | | 208,908 | | | | | | 211,786 | | | | | | 819,982 | | |
銷售商品成本
|
| | | | 130,030 | | | | | | 138,957 | | | | | | 139,839 | | | | | | 144,277 | | | | | | 553,103 | | |
毛利
|
| | | | 63,382 | | | | | | 66,919 | | | | | | 69,069 | | | | | | 67,509 | | | | | | 266,879 | | |
銷售,一般和管理費用
|
| | | | 40,995 | | | | | | 42,981 | | | | | | 42,577 | | | | | | 41,400 | | | | | | 167,953 | | |
營業收入
|
| | | | 22,387 | | | | | | 23,938 | | | | | | 26,492 | | | | | | 26,109 | | | | | | 98,926 | | |
利息費用,淨額
|
| | | | 3,118 | | | | | | 3,050 | | | | | | 3,064 | | | | | | 2,678 | | | | | | 11,910 | | |
外幣(收益)損失,淨額
|
| | | | 325 | | | | | | (323) | | | | | | (960) | | | | | | (96) | | | | | | (1,054) | | |
所得税前收入
|
| | | | 18,944 | | | | | | 21,211 | | | | | | 24,388 | | | | | | 23,527 | | | | | | 88,070 | | |
所得税準備金
|
| | | | 3,052 | | | | | | 14,179 | | | | | | 4,548 | | | | | | 1,408 | | | | | | 23,187 | | |
淨收入
|
| | | $ | 15,892 | | | | | $ | 7,032 | | | | | $ | 19,840 | | | | | $ | 22,119 | | | | | $ | 64,883 | | |
每股淨收益 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
基本型
|
| | | $ | 0.40 | | | | | $ | 0.17 | | | | | $ | 0.49 | | | | | $ | 0.55 | | | | | $ | 1.61 | | |
稀釋
|
| | | $ | 0.39 | | | | | $ | 0.17 | | | | | $ | 0.49 | | | | | $ | 0.55 | | | | | $ | 1.61 | | |
調整後EBITDA | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
動物健康
|
| | | $ | 33,742 | | | | | $ | 35,036 | | | | | $ | 36,292 | | | | | $ | 36,844 | | | | | $ | 141,914 | | |
礦質營養
|
| | | | 3,716 | | | | | | 5,614 | | | | | | 5,375 | | | | | | 3,878 | | | | | | 18,583 | | |
性能產品
|
| | | | 248 | | | | | | 264 | | | | | | 386 | | | | | | 983 | | | | | | 1,881 | | |
公司
|
| | | | (7,589) | | | | | | (8,436) | | | | | | (8,650) | | | | | | (8,745) | | | | | | (33,420) | | |
調整後EBITDA
|
| | | $ | 30,117 | | | | | $ | 32,478 | | | | | $ | 33,403 | | | | | $ | 32,960 | | | | | $ | 128,958 | | |
淨收益與調整後EBITDA的對賬
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
淨收入
|
| | | $ | 15,892 | | | | | $ | 7,032 | | | | | $ | 19,840 | | | | | $ | 22,119 | | | | | $ | 64,883 | | |
利息費用,淨額
|
| | | | 3,118 | | | | | | 3,050 | | | | | | 3,064 | | | | | | 2,678 | | | | | | 11,910 | | |
所得税準備金
|
| | | | 3,052 | | | | | | 14,179 | | | | | | 4,548 | | | | | | 1,408 | | | | | | 23,187 | | |
折舊攤銷
|
| | | | 6,644 | | | | | | 6,631 | | | | | | 6,751 | | | | | | 6,917 | | | | | | 26,943 | | |
EBITDA
|
| | | | 28,706 | | | | | | 30,892 | | | | | | 34,203 | | | | | | 33,122 | | | | | | 126,923 | | |
與收購相關的銷售商品成本
|
| | | | 249 | | | | | | 1,422 | | | | | | — | | | | | | — | | | | | | 1,671 | | |
與收購相關的應計補償
|
| | | | 437 | | | | | | 487 | | | | | | 160 | | | | | | 68 | | | | | | 1,152 | | |
與收購相關的交易成本
|
| | | | 400 | | | | | | — | | | | | | — | | | | | | — | | | | | | 400 | | |
與收購相關的其他,淨
|
| | | | — | | | | | | — | | | | | | — | | | | | | (468) | | | | | | (468) | | |
股票薪酬
|
| | | | — | | | | | | — | | | | | | — | | | | | | 334 | | | | | | 334 | | |
外幣(收益)損失,淨額
|
| | | | 325 | | | | | | (323) | | | | | | (960) | | | | | | (96) | | | | | | (1,054) | | |
調整後EBITDA
|
| | | $ | 30,117 | | | | | $ | 32,478 | | | | | $ | 33,403 | | | | | $ | 32,960 | | | | | $ | 128,958 | | |
|
獨立註冊會計師事務所報告
|
| | | | 81 | | |
|
截至6月30日、2019年、2018年和2017財年的合併運營報表
|
| | | | 83 | | |
|
截至2019年6月30日、2018年和
2017 |
| | | | 84 | | |
|
截至6月30日、2019年和2018年的綜合資產負債表
|
| | | | 85 | | |
|
截至6月30日、2019年、2018年和2017財年的現金流量表合併報表*
|
| | | | 86 | | |
|
截至2019年6月30日的會計年度股東權益變動綜合報表··
2018 and 2017. |
| | | | 87 | | |
|
截至6月30日、2019年、2018年和2017財年的合併財務報表註釋
|
| | | | 88 | | |
For the Year Ended June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |||||||||
| | |
(以千計,每股金額除外)
|
| |||||||||||||||
淨銷售額
|
| | | $ | 827,995 | | | | | $ | 819,982 | | | | | $ | 764,281 | | |
銷售商品成本
|
| | | | 563,371 | | | | | | 553,103 | | | | | | 516,038 | | |
毛利
|
| | | | 264,624 | | | | | | 266,879 | | | | | | 248,243 | | |
銷售,一般和管理費用
|
| | | | 181,398 | | | | | | 167,953 | | | | | | 150,309 | | |
營業收入
|
| | | | 83,226 | | | | | | 98,926 | | | | | | 97,934 | | |
利息費用,淨額
|
| | | | 11,776 | | | | | | 11,910 | | | | | | 14,906 | | |
外幣(收益)損失,淨額
|
| | | | (55) | | | | | | (1,054) | | | | | | (113) | | |
清償債務損失
|
| | | | — | | | | | | — | | | | | | 2,598 | | |
所得税前收入
|
| | | | 71,505 | | | | | | 88,070 | | | | | | 80,543 | | |
所得税準備金
|
| | | | 16,792 | | | | | | 23,187 | | | | | | 15,928 | | |
淨收入
|
| | | $ | 54,713 | | | | | $ | 64,883 | | | | | $ | 64,615 | | |
每股淨收益 | | | | | | | | | | | | | | | | | | | |
基本型
|
| | | $ | 1.35 | | | | | $ | 1.61 | | | | | $ | 1.63 | | |
稀釋
|
| | | $ | 1.35 | | | | | $ | 1.61 | | | | | $ | 1.61 | | |
加權平均已發行普通股 | | | | | |||||||||||||||
基本型
|
| | | | 40,412 | | | | | | 40,181 | | | | | | 39,524 | | |
稀釋
|
| | | | 40,523 | | | | | | 40,385 | | | | | | 40,042 | | |
For the Year Ended June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |||||||||
| | |
(千)
|
| |||||||||||||||
淨收入
|
| | | $ | 54,713 | | | | | $ | 64,883 | | | | | $ | 64,615 | | |
衍生工具公允價值變動
|
| | | | (5,580) | | | | | | 2,300 | | | | | | 31 | | |
外幣折算調整
|
| | | | (4,127) | | | | | | (23,542) | | | | | | (1,652) | | |
未確認的養老金淨收益(虧損)
|
| | | | (1,837) | | | | | | (154) | | | | | | 12,918 | | |
(規定)所得税福利
|
| | | | 1,846 | | | | | | 350 | | | | | | (4,949) | | |
其他綜合收益(虧損)
|
| | | | (9,698) | | | | | | (21,046) | | | | | | 6,348 | | |
綜合收益
|
| | | $ | 45,015 | | | | | $ | 43,837 | | | | | $ | 70,963 | | |
As of June 30
|
| |
2019
|
| |
2018
|
| ||||||
| | |
(除每股及每股金額外,以千計)
|
| |||||||||
資產 | | | | | | | | | | | | | |
現金及現金等價物
|
| | | $ | 57,573 | | | | | $ | 29,168 | | |
短期投資
|
| | | | 24,000 | | | | | | 50,000 | | |
應收帳款,淨額
|
| | | | 159,022 | | | | | | 135,742 | | |
庫存,淨額
|
| | | | 198,322 | | | | | | 178,170 | | |
其他流動資產
|
| | | | 27,245 | | | | | | 22,381 | | |
流動資產總額
|
| | | | 466,162 | | | | | | 415,461 | | |
財產,廠房和設備,淨額
|
| | | | 140,235 | | | | | | 130,108 | | |
無形資產,淨
|
| | | | 47,478 | | | | | | 51,978 | | |
商譽
|
| | | | 27,348 | | | | | | 27,348 | | |
其他資產
|
| | | | 45,448 | | | | | | 46,784 | | |
總資產
|
| | | $ | 726,671 | | | | | $ | 671,679 | | |
負債和股東權益 | | | | | | | | | | | | | |
長期債務的當期部分
|
| | | $ | 12,540 | | | | | $ | 12,579 | | |
應付帳款
|
| | | | 73,189 | | | | | | 59,498 | | |
應計費用和其他流動負債
|
| | | | 68,498 | | | | | | 71,144 | | |
流動負債總額
|
| | | | 154,227 | | | | | | 143,221 | | |
循環信貸工具
|
| | | | 96,000 | | | | | | 70,000 | | |
長期債務
|
| | | | 217,635 | | | | | | 229,802 | | |
其他負債
|
| | | | 42,794 | | | | | | 43,702 | | |
負債共計
|
| | | | 510,656 | | | | | | 486,725 | | |
承諾和或有事項(注8) | | | | | | | | | | | | | |
普通股,面值每股0.0001美元;300,000,000 A級
授權股份,發行20,287,574股和19,992,204股 並分別於6月30日、2019年和2018年表現突出; 30,000,000 B類股份授權,20,166,034和 20,365,504股已發行並於2019年6月30日流通股·2019年和 2018年,分別 |
| | | | 4 | | | | | | 4 | | |
優先股,每股面值0.0001美元;授權股票16,000,000股,未發行股票和未發行股票
|
| | | | — | | | | | | — | | |
實收資本
|
| | | | 133,266 | | | | | | 129,873 | | |
留存收益
|
| | | | 168,926 | | | | | | 131,560 | | |
累計其他綜合收益(虧損)
|
| | | | (86,181) | | | | | | (76,483) | | |
股東權益總額
|
| | | | 216,015 | | | | | | 184,954 | | |
總負債和股東權益
|
| | | $ | 726,671 | | | | | $ | 671,679 | | |
For the Year Ended June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |||||||||
| | |
(千)
|
| |||||||||||||||
經營活動 | | | | | | | | | | | | | | | | | | | |
淨收入
|
| | | $ | 54,713 | | | | | $ | 64,883 | | | | | $ | 64,615 | | |
調整淨收益與經營活動提供(使用)的現金淨額:
|
| | | | | | | | | | | | | | | | | | |
折舊攤銷
|
| | | | 27,564 | | | | | | 26,943 | | | | | | 26,001 | | |
債務發行成本攤銷和債務折價
|
| | | | 882 | | | | | | 883 | | | | | | 1,015 | | |
股票薪酬
|
| | | | 2,259 | | | | | | 334 | | | | | | — | | |
與採購相關的項目
|
| | | | — | | | | | | 3,908 | | | | | | 2,081 | | |
養老金結算成本
|
| | | | — | | | | | | — | | | | | | 1,702 | | |
遞延所得税
|
| | | | (105) | | | | | | 6,389 | | | | | | (28) | | |
外幣(收益)損失,淨額
|
| | | | (1,899) | | | | | | (635) | | | | | | (867) | | |
其他
|
| | | | (302) | | | | | | 1,181 | | | | | | 765 | | |
清償債務損失
|
| | | | — | | | | | | — | | | | | | 2,598 | | |
營業資產和負債的變動(扣除業務收購後):
|
| | | | | | | | | | | | | | | | | | |
應收帳款,淨額
|
| | | | (23,679) | | | | | | (11,900) | | | | | | (2,765) | | |
庫存,淨額
|
| | | | (20,982) | | | | | | (24,292) | | | | | | 5,432 | | |
其他流動資產
|
| | | | (7,173) | | | | | | 134 | | | | | | (3,012) | | |
其他資產
|
| | | | (299) | | | | | | (152) | | | | | | (1,504) | | |
應付帳款
|
| | | | 12,092 | | | | | | 2,446 | | | | | | (3,119) | | |
應計費用及其他負債
|
| | | | 4,098 | | | | | | (114) | | | | | | 5,471 | | |
經營活動提供的淨現金
|
| | | | 47,169 | | | | | | 70,008 | | | | | | 98,385 | | |
投資活動 | | | | | | | | | | | | | | | | | | | |
購買短期投資
|
| | | | (34,000) | | | | | | (82,000) | | | | | | — | | |
短期投資期限
|
| | | | 60,000 | | | | | | 32,000 | | | | | | — | | |
資本支出
|
| | | | (29,891) | | | | | | (18,548) | | | | | | (20,880) | | |
業務收購
|
| | | | (9,838) | | | | | | (15,000) | | | | | | — | | |
其他,淨
|
| | | | (404) | | | | | | (1,064) | | | | | | (1,062) | | |
投資活動使用的現金淨額
|
| | | | (14,133) | | | | | | (84,612) | | | | | | (21,942) | | |
融資活動 | | | | | | | | | | | | | | | | | | | |
循環信貸工具借款
|
| | | | 213,000 | | | | | | 225,000 | | | | | | 230,500 | | |
循環信用貸款償還
|
| | | | (187,000) | | | | | | (220,000) | | | | | | (234,500) | | |
長期債務收益
|
| | | | — | | | | | | — | | | | | | 250,000 | | |
支付長期債務、資本租賃和其他
|
| | | | (12,649) | | | | | | (6,401) | | | | | | (285,527) | | |
簽發應付購置單
|
| | | | 3,775 | | | | | | — | | | | | | — | | |
應付購置單付款
|
| | | | (3,775) | | | | | | — | | | | | | — | | |
債務發行成本
|
| | | | — | | | | | | — | | | | | | (3,925) | | |
發行普通股收益
|
| | | | 1,134 | | | | | | 5,699 | | | | | | 5,541 | | |
已支付股息
|
| | | | (18,592) | | | | | | (16,073) | | | | | | (15,827) | | |
籌資活動使用的現金淨額
|
| | | | (4,107) | | | | | | (11,775) | | | | | | (53,738) | | |
匯率變動對現金的影響
|
| | | | (524) | | | | | | (536) | | | | | | (227) | | |
現金及現金等價物淨增(減)
|
| | | | 28,405 | | | | | | (26,915) | | | | | | 22,478 | | |
期初現金及現金等價物
|
| | | | 29,168 | | | | | | 56,083 | | | | | | 33,605 | | |
期末現金及現金等價物
|
| | | $ | 57,573 | | | | | $ | 29,168 | | | | | $ | 56,083 | | |
補充現金流量信息 | | | | | | | | | | | | | | | | | | | |
已付利息
|
| | | $ | 12,250 | | | | | $ | 11,208 | | | | | $ | 14,600 | | |
已繳納所得税,淨額
|
| | | | 16,215 | | | | | | 15,191 | | | | | | 14,762 | | |
非現金投融資活動 | | | | | | | | | | | | | | | | | | | |
物業、廠房和設備以及資本租賃的增加
|
| | | | 2,890 | | | | | | 8,449 | | | | | | 1,550 | | |
| | |
股份
普普通通 股票 |
| |
普普通通
股票 |
| |
擇優
股票 |
| |
實收
資本 |
| |
留用
收益 |
| |
累積
其他 綜合 收入(虧損) |
| |
總計
|
| |||||||||||||||||||||
截至2016年6月30日
|
| | | | 39,407,568 | | | | | $ | 4 | | | | | $ | — | | | | | $ | 118,299 | | | | | $ | 33,962 | | | | | $ | (61,785) | | | | | $ | 90,480 | | |
綜合收益(虧損)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 64,615 | | | | | | 6,348 | | | | | | 70,963 | | |
股票期權的行使
|
| | | | 468,400 | | | | | | — | | | | | | — | | | | | | 5,541 | | | | | | — | | | | | | — | | | | | | 5,541 | | |
已宣派股息(每股0.40美元)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (15,827) | | | | | | — | | | | | | (15,827) | | |
As of June 30, 2017
|
| | | | 39,875,968 | | | | | $ | 4 | | | | | $ | — | | | | | $ | 123,840 | | | | | $ | 82,750 | | | | | $ | (55,437) | | | | | $ | 151,157 | | |
綜合收益(虧損)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 64,883 | | | | | | (21,046) | | | | | | 43,837 | | |
股票期權的行使
|
| | | | 481,740 | | | | | | — | | | | | | — | | | | | | 5,699 | | | | | | — | | | | | | — | | | | | | 5,699 | | |
已宣派股息(每股0.40美元)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (16,073) | | | | | | — | | | | | | (16,073) | | |
股票補償費用
|
| | | | — | | | | | | — | | | | | | — | | | | | | 334 | | | | | | — | | | | | | — | | | | | | 334 | | |
As of June 30, 2018
|
| | | | 40,357,708 | | | | | $ | 4 | | | | | $ | — | | | | | $ | 129,873 | | | | | $ | 131,560 | | | | | $ | (76,483) | | | | | $ | 184,954 | | |
採用新的收入標準
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,245 | | | | | | — | | | | | | 1,245 | | |
綜合收益(虧損)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 54,713 | | | | | | (9,698) | | | | | | 45,015 | | |
股票期權的行使
|
| | | | 95,900 | | | | | | — | | | | | | — | | | | | | 1,134 | | | | | | — | | | | | | — | | | | | | 1,134 | | |
已宣派股息(每股0.46美元)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (18,592) | | | | | | — | | | | | | (18,592) | | |
股票補償費用
|
| | | | — | | | | | | — | | | | | | — | | | | | | 2,259 | | | | | | — | | | | | | — | | | | | | 2,259 | | |
As of June 30, 2019
|
| | | | 40,453,608 | | | | | $ | 4 | | | | | $ | — | | | | | $ | 133,266 | | | | | $ | 168,926 | | | | | $ | (86,181) | | | | | $ | 216,015 | | |
For the Year Ended June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |||||||||
淨收入
|
| | | $ | 54,713 | | | | | $ | 64,883 | | | | | $ | 64,615 | | |
加權平均股份數-基本
|
| | | | 40,412 | | | | | | 40,181 | | | | | | 39,524 | | |
股票期權和限制性股票單位的稀釋效應
|
| | | | 111 | | | | | | 204 | | | | | | 518 | | |
加權平均股數-稀釋
|
| | | | 40,523 | | | | | | 40,385 | | | | | | 40,042 | | |
每股淨收益 | | | | | |||||||||||||||
基本型
|
| | | $ | 1.35 | | | | | $ | 1.61 | | | | | $ | 1.63 | | |
稀釋
|
| | | $ | 1.35 | | | | | $ | 1.61 | | | | | $ | 1.61 | | |
As of July 1, 2018
|
| |
vt.影響,影響
收養 |
| |
Post-adoption
|
| ||||||
其他流動資產
|
| | | $ | 2,100 | | | | | $ | 24,481 | | |
其他資產
|
| | | | 2,325 | | | | | | 49,109 | | |
應計費用和其他流動負債
|
| | | | 343 | | | | | | 71,487 | | |
其他負債
|
| | | | 2,837 | | | | | | 46,539 | | |
留存收益
|
| | | $ | 1,245 | | | | | $ | 132,805 | | |
As of June 30, 2019
|
| |
vt.影響,影響
收養 |
| |
As reported
|
| ||||||
其他流動資產
|
| | | $ | 225 | | | | | $ | 27,245 | | |
其他資產
|
| | | | 225 | | | | | | 45,448 | | |
其他負債
|
| | | | (216) | | | | | | 42,794 | | |
留存收益
|
| | | $ | 666 | | | | | $ | 168,926 | | |
For the Year Ended June 30, 2019
|
| |
vt.影響,影響
收養 |
| |
As reported
|
| ||||||
淨銷售額
|
| | | $ | 793 | | | | | $ | 827,995 | | |
所得税準備金
|
| | | | 127 | | | | | | 16,792 | | |
淨收入
|
| | | $ | 666 | | | | | $ | 54,713 | | |
For the Year Ended June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |||||||||
動物健康 | | | | | |||||||||||||||
MFA和其他
|
| | | $ | 350,468 | | | | | $ | 336,666 | | | | | $ | 321,430 | | |
營養專科
|
| | | | 113,215 | | | | | | 122,978 | | | | | | 111,282 | | |
疫苗
|
| | | | 68,291 | | | | | | 72,083 | | | | | | 65,033 | | |
動物衞生總量
|
| | | $ | 531,974 | | | | | $ | 531,727 | | | | | $ | 497,745 | | |
礦質營養
|
| | | | 233,782 | | | | | | 234,922 | | | | | | 218,298 | | |
性能產品
|
| | | | 62,239 | | | | | | 53,333 | | | | | | 48,238 | | |
總計
|
| | | $ | 827,995 | | | | | $ | 819,982 | | | | | $ | 764,281 | | |
For the Year Ended June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |||||||||
美國
|
| | | $ | 480,101 | | | | | $ | 490,880 | | | | | $ | 483,794 | | |
拉丁美洲和加拿大
|
| | | | 152,380 | | | | | | 143,231 | | | | | | 113,187 | | |
歐洲、中東和非洲
|
| | | | 105,365 | | | | | | 110,377 | | | | | | 95,838 | | |
亞太
|
| | | | 90,149 | | | | | | 75,494 | | | | | | 71,462 | | |
總計
|
| | | $ | 827,995 | | | | | $ | 819,982 | | | | | $ | 764,281 | | |
For the Year Ended June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |||||||||
利息費用,淨額 | | | | | |||||||||||||||
定期貸款
|
| | | $ | 8,553 | | | | | $ | 8,321 | | | | | $ | 11,482 | | |
循環信貸工具
|
| | | | 3,748 | | | | | | 2,777 | | | | | | 2,897 | | |
債務發行成本攤銷和債務折價
|
| | | | 882 | | | | | | 883 | | | | | | 1,015 | | |
與收購相關的應計利息
|
| | | | — | | | | | | 1,085 | | | | | | 1,373 | | |
其他
|
| | | | 494 | | | | | | 537 | | | | | | 105 | | |
利息費用
|
| | | | 13,677 | | | | | | 13,603 | | | | | | 16,872 | | |
利息(收入)
|
| | | | (1,901) | | | | | | (1,693) | | | | | | (1,966) | | |
| | | | $ | 11,776 | | | | | $ | 11,910 | | | | | $ | 14,906 | | |
|
For the Year Ended June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |||||||||
折舊攤銷 | | | | | |||||||||||||||
財產、廠房和設備折舊
|
| | | $ | 21,423 | | | | | $ | 21,044 | | | | | $ | 19,916 | | |
無形資產攤銷
|
| | | | 6,092 | | | | | | 5,851 | | | | | | 5,950 | | |
其他資產攤銷
|
| | | | 49 | | | | | | 48 | | | | | | 135 | | |
| | | | $ | 27,564 | | | | | $ | 26,943 | | | | | $ | 26,001 | | |
For the Year Ended June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |||||||||
研發支出
|
| | | $ | 12,083 | | | | | $ | 9,998 | | | | | $ | 9,442 | | |
|
As of June 30
|
| |
2019
|
| |
2018
|
| ||||||
應收帳款,淨額 | | | | ||||||||||
應收貿易賬款
|
| | | $ | 163,464 | | | | | $ | 141,999 | | |
呆賬備抵
|
| | | | (4,442) | | | | | | (6,257) | | |
| | | | $ | 159,022 | | | | | $ | 135,742 | | |
|
As of June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |||||||||
呆賬備抵 | | | | | |||||||||||||||
期初餘額
|
| | | $ | 6,257 | | | | | $ | 6,428 | | | | | $ | 4,953 | | |
壞賬準備
|
| | | | (201) | | | | | | 166 | | | | | | 1,412 | | |
匯率變動的影響
|
| | | | 38 | | | | | | (215) | | | | | | 159 | | |
壞賬核銷
|
| | | | (1,500) | | | | | | — | | | | | | — | | |
壞賬回收
|
| | | | (152) | | | | | | (122) | | | | | | (96) | | |
期末餘額
|
| | | $ | 4,442 | | | | | $ | 6,257 | | | | | $ | 6,428 | | |
|
As of June 30
|
| |
2019
|
| |
2018
|
| ||||||
盤存 | | | | ||||||||||
原料
|
| | | $ | 64,441 | | | | | $ | 62,373 | | |
在製品
|
| | | | 10,699 | | | | | | 14,731 | | |
成品
|
| | | | 123,182 | | | | | | 101,066 | | |
| | | | $ | 198,322 | | | | | $ | 178,170 | | |
|
As of June 30
|
| |
2019
|
| |
2018
|
| ||||||
財產,廠房和設備,淨額 | | | | ||||||||||
土地
|
| | | $ | 10,152 | | | | | $ | 10,140 | | |
建築和改善
|
| | | | 71,036 | | | | | | 68,769 | | |
機械設備
|
| | | | 252,097 | | | | | | 227,092 | | |
| | | | | 333,285 | | | | | | 306,001 | | |
累計折舊
|
| | | | (193,050) | | | | | | (175,893) | | |
| | | | $ | 140,235 | | | | | $ | 130,108 | | |
As of June 30
|
| |
加權-
平均值 使用壽命 (年) |
| |
2019
|
| |
2018
|
| |||||||||
無形資產,淨 | | | | | |||||||||||||||
成本 | | | | | |||||||||||||||
工藝
|
| | | | 13 | | | | | $ | 71,016 | | | | | $ | 69,475 | | |
產品註冊,營銷和分發權
|
| | | | 9 | | | | | | 17,858 | | | | | | 17,902 | | |
客户關係
|
| | | | 13 | | | | | | 12,194 | | | | | | 12,211 | | |
商品名稱、商標及其他
|
| | | | 5 | | | | | | 2,740 | | | | | | 2,740 | | |
正在進行的研究和開發
|
| | | | | | | | | | 1,800 | | | | | | 1,800 | | |
| | | | | | | | | | | 105,608 | | | | | | 104,128 | | |
累計攤銷 | | | | | |||||||||||||||
工藝
|
| | | | | | | | | | (29,333) | | | | | | (23,937) | | |
產品註冊,營銷和分發權
|
| | | | | | | | | | (17,811) | | | | | | (17,902) | | |
客户關係
|
| | | | | | | | | | (8,282) | | | | | | (7,614) | | |
商品名稱、商標及其他
|
| | | | | | | | | | (2,704) | | | | | | (2,697) | | |
| | | | | | | | | | | (58,130) | | | | | | (52,150) | | |
| | | | | | | | | | $ | 47,478 | | | | | $ | 51,978 | | |
|
As of June 30
|
| |
2019
|
| |
2018
|
| ||||||
商譽前滾 | | | | ||||||||||
期初餘額
|
| | | $ | 27,348 | | | | | $ | 23,982 | | |
採辦
|
| | | | — | | | | | | 5,642 | | |
翻譯
|
| | | | — | | | | | | (2,276) | | |
期末餘額
|
| | | $ | 27,348 | | | | | $ | 27,348 | | |
As of June 30
|
| |
2019
|
| |
2018
|
| ||||||
其他資產 | | | | ||||||||||
權益法投資
|
| | | $ | 4,196 | | | | | $ | 3,944 | | |
保險投資
|
| | | | 5,431 | | | | | | 5,235 | | |
遞延融資費
|
| | | | 1,531 | | | | | | 2,042 | | |
遞延所得税
|
| | | | 16,770 | | | | | | 15,424 | | |
存款
|
| | | | 7,024 | | | | | | 6,692 | | |
賠償資產
|
| | | | 3,000 | | | | | | 3,000 | | |
衍生工具公允價值
|
| | | | — | | | | | | 5,078 | | |
其他
|
| | | | 7,496 | | | | | | 5,369 | | |
| | | | $ | 45,448 | | | | | $ | 46,784 | | |
As of June 30
|
| |
2019
|
| |
2018
|
| ||||||
應計費用和其他流動負債 | | | | ||||||||||
員工相關
|
| | | $ | 28,298 | | | | | $ | 27,333 | | |
佣金和回扣
|
| | | | 8,397 | | | | | | 7,341 | | |
保險相關
|
| | | | 1,279 | | | | | | 1,168 | | |
專業費用
|
| | | | 5,212 | | | | | | 4,350 | | |
所得税和其他税
|
| | | | 6,067 | | | | | | 3,610 | | |
與收購相關的注意事項
|
| | | | — | | | | | | 12,845 | | |
重組成本
|
| | | | 3,590 | | | | | | — | | |
其他
|
| | | | 15,655 | | | | | | 14,497 | | |
| | | | $ | 68,498 | | | | | $ | 71,144 | | |
As of June 30
|
| |
2019
|
| |
2018
|
| ||||||
其他負債 | | | | ||||||||||
美國養老金計劃
|
| | | $ | 3,934 | | | | | $ | 2,910 | | |
國際退休計劃
|
| | | | 5,133 | | | | | | 4,644 | | |
補充退休福利、遞延補償和其他
|
| | | | 7,605 | | | | | | 10,792 | | |
長期所得税和遞延所得税
|
| | | | 8,978 | | | | | | 9,729 | | |
重組成本
|
| | | | 2,000 | | | | | | — | | |
其他長期負債
|
| | | | 15,144 | | | | | | 15,627 | | |
| | | | $ | 42,794 | | | | | $ | 43,702 | | |
|
As of June 30
|
| |
2019
|
| |
2018
|
| ||||||
累計其他綜合收益(虧損) | | | | ||||||||||
衍生工具
|
| | | $ | (594) | | | | | $ | 4,986 | | |
外幣折算調整
|
| | | | (71,225) | | | | | | (67,098) | | |
未確認的養老金淨收益(虧損)
|
| | | | (20,050) | | | | | | (18,213) | | |
(規定)衍生工具所得税利益
|
| | | | 148 | | | | | | (1,241) | | |
(撥備)長期公司間投資所得税福利
|
| | | | 8,166 | | | | | | 8,166 | | |
(規定)養老金收益(損失)所得税福利
|
| | | | (2,626) | | | | | | (3,083) | | |
| | | | $ | (86,181) | | | | | $ | (76,483) | | |
As of June 30
|
| |
2019
|
| |
2018
|
| ||||||
期限A貸款到期6月·2022
|
| | | $ | 231,250 | | | | | $ | 243,750 | | |
資本化租賃義務
|
| | | | 40 | | | | | | 118 | | |
| | | | | 231,290 | | | | | | 243,868 | | |
未攤銷債務發行成本和債務貼現
|
| | | | (1,115) | | | | | | (1,487) | | |
| | | | | 230,175 | | | | | | 242,381 | | |
減:當前到期日
|
| | | | (12,540) | | | | | | (12,579) | | |
| | | | $ | 217,635 | | | | | $ | 229,802 | | |
|
For the Year Ended June 30
|
| | |||||
2020
|
| | | $ | 12,540 | | |
2021
|
| | | | 18,750 | | |
2022
|
| | | | 200,000 | | |
總計
|
| | | $ | 231,290 | | |
| | |
2019
|
| |
2018
|
| | | | | | | |
2019
|
| |
2018
|
| ||||||||||||
As of June 30
|
| |
授權股份
|
| |
面值
|
| |
已發行和已發行股份
|
| |||||||||||||||||||||
優先股
|
| | | | 16,000,000 | | | | | | 16,000,000 | | | | | $ | 0.0001 | | | | | | — | | | | | | — | | |
普通股-A類
|
| | | | 300,000,000 | | | | | | 300,000,000 | | | | | $ | 0.0001 | | | | | | 20,287,574 | | | | | | 19,992,204 | | |
普通股-B類
|
| | | | 30,000,000 | | | | | | 30,000,000 | | | | | $ | 0.0001 | | | | | | 20,166,034 | | | | | | 20,365,504 | | |
| | |
RSU
|
| |
授予日期
公允價值 每RSU·共享 |
| |
授予日期
公允價值 |
| |||||||||
授予基於性能的RSU
May 2018 |
| | | | 200,000 | | | | | $ | 19.63 | | | | | $ | 3,926 | | |
2018年5月授予基於時間的RSU
|
| | | | 50,000 | | | | | $ | 41.10 | | | | | $ | 2,055 | | |
傑出的6月30日,2019年和2018年
|
| | | | 250,000 | | | | | $ | 23.92 | | | | | $ | 5,981 | | |
| | |
選擇權
股份 |
| |
加權平均
行使價格 每股 |
| ||||||
傑出,2018年6月30日
|
| | | | 95,900 | | | | | $ | 11.83 | | |
已行使
|
| | | | (95,900) | | | | | $ | 11.83 | | |
傑出,6月30日,2019年
|
| | | | — | | | | | $ | — | | |
For the Year Ended June 30
|
| |
2019
|
| |
2018
|
| ||||||
預計福利義務的變化 | | | | ||||||||||
年初預計福利義務
|
| | | $ | 61,557 | | | | | $ | 63,260 | | |
利息成本
|
| | | | 2,407 | | | | | | 2,157 | | |
已付福利
|
| | | | (1,758) | | | | | | (2,196) | | |
精算(收益)損失
|
| | | | 6,321 | | | | | | (1,664) | | |
年終預計福利義務
|
| | | $ | 68,527 | | | | | $ | 61,557 | | |
|
For the Year Ended June 30
|
| |
2019
|
| |
2018
|
| ||||||
計劃資產變動 | | | | ||||||||||
年初計劃資產公允價值
|
| | | $ | 58,648 | | | | | $ | 57,110 | | |
計劃資產實際收益
|
| | | | 6,860 | | | | | | 965 | | |
僱主供款
|
| | | | 842 | | | | | | 2,768 | | |
已付福利
|
| | | | (1,757) | | | | | | (2,195) | | |
年終計劃資產公允價值
|
| | | $ | 64,593 | | | | | $ | 58,648 | | |
年終資金狀況
|
| | | $ | (3,934) | | | | | $ | (2,909) | | |
For the Year Ended June 30
|
| |
2019
|
| |
2018
|
| ||||||
累計與養老金計劃相關的其他綜合收入(虧損)
|
| | | | | | | | | | | | |
期初餘額
|
| | | $ | (18,213) | | | | | $ | (18,059) | | |
精算淨損失攤銷
|
| | | | 465 | | | | | | 453 | | |
本期淨精算(虧損)收益
|
| | | | (2,302) | | | | | | (607) | | |
淨變化
|
| | | | (1,837) | | | | | | (154) | | |
期末餘額
|
| | | $ | (20,050) | | | | | $ | (18,213) | | |
For the Year Ended June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |||||||||
服務成本-年內獲得的收益
|
| | | $ | — | | | | | $ | — | | | | | $ | 845 | | |
利益義務的利息成本
|
| | | | 2,407 | | | | | | 2,157 | | | | | | 2,045 | | |
計劃資產預期收益
|
| | | | (2,842) | | | | | | (3,236) | | | | | | (3,389) | | |
精算淨損失攤銷
|
| | | | 465 | | | | | | 453 | | | | | | 672 | | |
削減費用
|
| | | | — | | | | | | — | | | | | | 16 | | |
結算費用
|
| | | | — | | | | | | — | | | | | | 1,702 | | |
定期養老金費用淨額
|
| | | $ | 30 | | | | | $ | (626) | | | | | $ | 1,891 | | |
|
For the Year Ended June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |||||||||
服務成本貼現率
|
| | | | 不適用 | | | | | | 不適用 | | | | | | 4.0% | | |
利息成本貼現率
|
| | | | 3.1% | | | | | | 3.9% | | | | | | 3.2% | | |
計劃資產預期收益率
|
| | | | 4.9% | | | | | | 5.6% | | | | | | 6.1% | | |
年終福利義務貼現率
|
| | | | 3.6% | | | | | | 4.2% | | | | | | 3.9% | | |
For the Year Ended June 30
|
| | |||||
2020
|
| | | $ | 2,599 | | |
2021
|
| | | | 2,878 | | |
2022
|
| | | | 3,113 | | |
2023
|
| | | | 3,318 | | |
2024
|
| | | | 3,474 | | |
2025–2029
|
| | | | 18,828 | | |
| | |
靶子
分配 |
| |
計劃資產百分比
|
| |||||||||
For the Year Ended June 30
|
| |
2020
|
| |
2019
|
| |
2018
|
| ||||||
債務證券
|
| |
57%–77%
|
| | | | 67% | | | | | | 63% | | |
股權證券
|
| |
18%–38%
|
| | | | 28% | | | | | | 26% | | |
全球資產配置/風險平價(1)
|
| |
0%–15%
|
| | | | 4% | | | | | | 10% | | |
其他
|
| |
0%–10%
|
| | | | 1% | | | | | | 1% | | |
| | |
公允價值計量使用
|
| |||||||||||||||||||||
As of June 30, 2019
|
| |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total
|
| ||||||||||||
現金及現金等價物
|
| | | $ | 215 | | | | | $ | — | | | | | $ | — | | | | | $ | 215 | | |
共同集體基金 | | | | | | ||||||||||||||||||||
全球大盤股
|
| | | | — | | | | | | 13,995 | | | | | | 4,016 | | | | | | 18,011 | | |
固定收益證券
|
| | | | — | | | | | | 43,288 | | | | | | — | | | | | | 43,288 | | |
全球資產配置/風險平價
|
| | | | — | | | | | | 1,446 | | | | | | — | | | | | | 1,446 | | |
其他 | | | | | | ||||||||||||||||||||
全球資產配置/風險平價
|
| | | | — | | | | | | — | | | | | | 1,447 | | | | | | 1,447 | | |
其他
|
| | | | — | | | | | | — | | | | | | 186 | | | | | | 186 | | |
| | | | $ | 215 | | | | | $ | 58,729 | | | | | $ | 5,649 | | | | | $ | 64,593 | | |
|
| | |
公允價值計量使用
|
| |||||||||||||||||||||
As of June 30, 2018
|
| |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total
|
| ||||||||||||
現金及現金等價物
|
| | | $ | 428 | | | | | $ | — | | | | | $ | — | | | | | $ | 428 | | |
共同集體基金 | | | | | | ||||||||||||||||||||
全球大盤股
|
| | | | — | | | | | | 11,632 | | | | | | 3,811 | | | | | | 15,443 | | |
固定收益證券
|
| | | | — | | | | | | 36,671 | | | | | | — | | | | | | 36,671 | | |
全球資產配置/風險平價
|
| | | | — | | | | | | 2,957 | | | | | | — | | | | | | 2,957 | | |
其他 | | | | | | ||||||||||||||||||||
全球資產配置/風險平價
|
| | | | — | | | | | | — | | | | | | 2,881 | | | | | | 2,881 | | |
其他
|
| | | | — | | | | | | — | | | | | | 268 | | | | | | 268 | | |
| | | | $ | 428 | | | | | $ | 51,260 | | | | | $ | 6,960 | | | | | $ | 58,648 | | |
3級資產公允價值變動
|
| |
2019
|
| |
2018
|
| ||||||
期初餘額
|
| | | $ | 6,960 | | | | | $ | 15,959 | | |
贖回
|
| | | | (4,336) | | | | | | (9,901) | | |
購貨
|
| | | | 2,800 | | | | | | — | | |
公允價值變動
|
| | | | 225 | | | | | | 902 | | |
期末餘額
|
| | | $ | 5,649 | | | | | $ | 6,960 | | |
For the Year Ended June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |||||||||
國內
|
| | | $ | 2,331 | | | | | $ | 19,819 | | | | | $ | 18,015 | | |
外方
|
| | | | 69,174 | | | | | | 68,251 | | | | | | 62,528 | | |
所得税前收入
|
| | | $ | 71,505 | | | | | $ | 88,070 | | | | | $ | 80,543 | | |
|
For the Year Ended June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |||||||||
當前撥備(福利): | | | | | |||||||||||||||
聯邦制
|
| | | $ | (459) | | | | | $ | 81 | | | | | $ | 383 | | |
州和地方
|
| | | | 102 | | | | | | 1,744 | | | | | | 724 | | |
外方
|
| | | | 16,603 | | | | | | 15,268 | | | | | | 14,839 | | |
流動總撥備
|
| | | | 16,246 | | | | | | 17,093 | | | | | | 15,946 | | |
遞延撥備(福利): | | | | | |||||||||||||||
聯邦制
|
| | | | 858 | | | | | | 2,746 | | | | | | 4,675 | | |
州和地方
|
| | | | 432 | | | | | | 2,156 | | | | | | 251 | | |
外方
|
| | | | (691) | | | | | | 769 | | | | | | (833) | | |
估價免税額變動-國外
|
| | | | (53) | | | | | | 423 | | | | | | (4,111) | | |
遞延準備金總額(福利)
|
| | | | 546 | | | | | | 6,094 | | | | | | (18) | | |
所得税準備金
|
| | | $ | 16,792 | | | | | $ | 23,187 | | | | | $ | 15,928 | | |
For the Year Ended June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |||||||||
聯邦所得税税率
|
| | | | 21.0% | | | | | | 28.1% | | | | | | 35.0% | | |
州和地方税,扣除聯邦利益
|
| | | | 0.6 | | | | | | 1.5 | | | | | | 0.9 | | |
國外所得税税率
|
| | | | 6.9 | | | | | | (1.5) | | | | | | (6.8) | | |
國外激勵税率
|
| | | | (2.8) | | | | | | (3.3) | | | | | | (3.1) | | |
國外所得税國內税
|
| | | | — | | | | | | — | | | | | | 2.7 | | |
不確定税收狀況的變化
|
| | | | (1.0) | | | | | | 1.1 | | | | | | 1.6 | | |
永久項目
|
| | | | 0.6 | | | | | | 0.5 | | | | | | (0.9) | | |
員工股票期權的行使
|
| | | | (0.4) | | | | | | (4.3) | | | | | | (3.8) | | |
全球無形低税收入
|
| | | | 0.8 | | | | | | — | | | | | | — | | |
強制徵收税法通行費
|
| | | | (0.5) | | | | | | 0.5 | | | | | | — | | |
國內遞延税金資產減少
|
| | | | — | | | | | | 2.6 | | | | | | — | | |
減少國外遞延税金資產
|
| | | | — | | | | | | 1.3 | | | | | | — | | |
承認聯邦税收抵免
|
| | | | (1.1) | | | | | | — | | | | | | — | | |
承認外國税收抵免
|
| | | | (1.4) | | | | | | (0.7) | | | | | | — | | |
從累計的其他綜合收入重新分類
|
| | | | — | | | | | | 0.6 | | | | | | — | | |
放行外國估價津貼
|
| | | | — | | | | | | — | | | | | | (5.1) | | |
其他
|
| | | | (0.8) | | | | | | (0.1) | | | | | | (0.7) | | |
有效税率
|
| | | | 23.5% | | | | | | 26.3% | | | | | | 19.8% | | |
As of June 30
|
| |
2019
|
| |
2018
|
| ||||||
遞延税項資產: | | | | ||||||||||
員工相關應計
|
| | | $ | 5,735 | | | | | $ | 4,952 | | |
盤存
|
| | | | 4,766 | | | | | | 3,953 | | |
環境修復
|
| | | | 1,128 | | | | | | 1,341 | | |
淨營業虧損結轉-國內
|
| | | | 902 | | | | | | 1,577 | | |
淨營業虧損結轉-國外
|
| | | | 3,703 | | | | | | 3,243 | | |
其他
|
| | | | 6,302 | | | | | | 9,986 | | |
| | | | | 22,536 | | | | | | 25,052 | | |
估價津貼
|
| | | | (808) | | | | | | (861) | | |
| | | | | 21,728 | | | | | | 24,191 | | |
遞延税金負債: | | | | ||||||||||
財產、廠房、設備和無形資產
|
| | | | (6,071) | | | | | | (8,957) | | |
其他
|
| | | | (772) | | | | | | (1,906) | | |
| | | | | (6,843) | | | | | | (10,863) | | |
遞延税金淨資產
|
| | | $ | 14,885 | | | | | $ | 13,328 | | |
As of June 30
|
| |
2019
|
| |
2018
|
| ||||||
其他資產
|
| | | $ | 16,770 | | | | | $ | 15,424 | | |
其他負債
|
| | | | (1,885) | | | | | | (2,096) | | |
| | | | $ | 14,885 | | | | | $ | 13,328 | | |
As of June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |||||||||
期初餘額
|
| | | $ | 861 | | | | | $ | 438 | | | | | $ | 4,614 | | |
所得税準備金
|
| | | | (53) | | | | | | 423 | | | | | | (4,111) | | |
淨營業損失利用率
|
| | | | — | | | | | | — | | | | | | (65) | | |
期末餘額
|
| | | $ | 808 | | | | | $ | 861 | | | | | $ | 438 | | |
As of June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |||||||||
未確認的税收優惠-期初
|
| | | $ | 7,000 | | | | | $ | 6,553 | | | | | $ | 4,946 | | |
税位變動-本期
|
| | | | 528 | | | | | | 1,749 | | | | | | 1,490 | | |
税收狀況變化-前期,減去與税務當局的結算淨額
|
| | | | (317) | | | | | | (994) | | | | | | — | | |
訴訟時效的失效
|
| | | | (1,053) | | | | | | — | | | | | | (391) | | |
翻譯
|
| | | | 185 | | | | | | (308) | | | | | | 508 | | |
未確認的税收優惠-期末
|
| | | | 6,343 | | | | | | 7,000 | | | | | | 6,553 | | |
利息和罰金-期末
|
| | | | 750 | | | | | | 633 | | | | | | 449 | | |
與不確定税相關的總負債
職位 |
| | | $ | 7,093 | | | | | $ | 7,633 | | | | | $ | 7,002 | | |
For the Year Ended June 30
|
| |
資本
租約 |
| |
不可取消
經營租賃 |
| ||||||
2020
|
| | | $ | 40 | | | | | $ | 5,815 | | |
2021
|
| | | | — | | | | | | 4,160 | | |
2022
|
| | | | — | | | | | | 3,191 | | |
2023
|
| | | | — | | | | | | 1,445 | | |
2024
|
| | | | | | | | | | 865 | | |
此後
|
| | | | — | | | | | | 765 | | |
最低租賃付款總額
|
| | | $ | 40 | | | | | $ | 16,241 | | |
Instrument
|
| |
樹籬
|
| |
概念
金額 June 30, 2019 |
| |
固形
資產負債表 |
| |
資產(負債)
公允價值截至 |
| |||||||||
|
六月三十日
2019 |
| |
六月三十日
2018 |
| |||||||||||||||||
選項
|
| |
巴西皇馬呼叫
|
| |
R$ 43,000
|
| |
(1)
|
| | | $ | 413 | | | | | $ | 71 | | |
選項
|
| |
巴西雷亞爾看跌期權
|
| |
R$ 43,000
|
| |
(1)
|
| | | $ | (30) | | | | | $ | — | | |
互換
|
| | 利率互換 | | |
$150,000
|
| |
其他資產
(其他負債) |
| | | $ | (977) | | | | | $ | 5,078 | | |
For the Year Ended June 30
|
| |
OCI記錄的收益(損失)
|
| |
合併確認損益
經營報表 |
| |
合併報表
操作行項目合計 |
| |||||||||||||||||||||||||||||||||
Instrument
|
| |
Hedge
|
| |
2019
|
| |
2018
|
| |
固形
聲明 運籌學 |
| |
2019
|
| |
2018
|
| |
2019
|
| |
2018
|
| ||||||||||||||||||
選項 | | |
巴西皇馬呼叫
|
| | | $ | 475 | | | | | $ | (2,778) | | | |
銷售商品成本
|
| | | $ | 1,069 | | | | | $ | 3,136 | | | | | $ | 563,371 | | | | | $ | 553,103 | | |
互換
|
| |
利率互換
|
| | | $ | (6,055) | | | | | $ | 5,078 | | | |
利息費用,淨額
|
| | | $ | — | | | | | $ | — | | | | | $ | 11,776 | | | | | $ | 11,910 | | |
As of June 30
|
| |
2019
|
| |
2018
|
| ||||||||||||||||||
| | |
1級
|
| |
標高·2
|
| |
1級
|
| |
標高·2
|
| ||||||||||||
短期投資
|
| | | $ | 24,000 | | | | | $ | — | | | | | $ | 50,000 | | | | | $ | — | | |
衍生品資產(負債)
|
| | | $ | — | | | | | $ | 383 | | | | | $ | — | | | | | $ | 71 | | |
利率掉期(負債)
|
| | | $ | — | | | | | $ | (977) | | | | | $ | — | | | | | $ | 5,078 | | |
For the Year Ended June 30
|
| |
2019
|
| |
2018
|
| |
2017
|
| |||||||||
淨銷售額 | | | | | | | | | | | | | | | | | | | |
動物健康
|
| | | $ | 531,974 | | | | | $ | 531,727 | | | | | $ | 497,745 | | |
礦質營養
|
| | | | 233,782 | | | | | | 234,922 | | | | | | 218,298 | | |
性能產品
|
| | | | 62,239 | | | | | | 53,333 | | | | | | 48,238 | | |
總線段
|
| | | $ | 827,995 | | | | | $ | 819,982 | | | | | $ | 764,281 | | |
折舊攤銷 | | | | | | | | | | | | | | | | | | | |
動物健康
|
| | | $ | 22,312 | | | | | $ | 21,447 | | | | | $ | 20,132 | | |
礦質營養
|
| | | | 2,319 | | | | | | 2,371 | | | | | | 2,332 | | |
性能產品
|
| | | | 1,127 | | | | | | 1,029 | | | | | | 939 | | |
總線段
|
| | | $ | 25,758 | | | | | $ | 24,847 | | | | | $ | 23,403 | | |
調整後EBITDA | | | | | | | | | | | | | | | | | | | |
動物健康
|
| | | $ | 136,049 | | | | | $ | 141,914 | | | | | $ | 130,261 | | |
礦質營養
|
| | | | 15,712 | | | | | | 18,583 | | | | | | 17,426 | | |
性能產品
|
| | | | 4,728 | | | | | | 1,881 | | | | | | 2,057 | | |
總線段
|
| | | $ | 156,489 | | | | | $ | 162,378 | | | | | $ | 149,744 | | |
所得税前收入調節至
調整後EBITDA |
| | | | | | | | | | | | | | | | | | |
所得税前收入
|
| | | $ | 71,505 | | | | | $ | 88,070 | | | | | $ | 80,543 | | |
利息費用,淨額
|
| | | | 11,776 | | | | | | 11,910 | | | | | | 14,906 | | |
折舊和攤銷-總細分
|
| | | | 25,758 | | | | | | 24,847 | | | | | | 23,403 | | |
折舊和攤銷-公司
|
| | | | 1,806 | | | | | | 2,096 | | | | | | 2,598 | | |
公司成本
|
| | | | 38,452 | | | | | | 33,420 | | | | | | 29,625 | | |
重組成本
|
| | | | 6,281 | | | | | | — | | | | | | — | | |
股票薪酬
|
| | | | 2,259 | | | | | | 334 | | | | | | — | | |
與收購相關的銷售商品成本
|
| | | | — | | | | | | 1,671 | | | | | | — | | |
與收購相關的應計補償
|
| | | | — | | | | | | 1,152 | | | | | | 1,680 | | |
與收購相關的交易成本
|
| | | | 213 | | | | | | 400 | | | | | | 1,274 | | |
與收購相關的其他,淨
|
| | | | — | | | | | | (468) | | | | | | (972) | | |
其他
|
| | | | (1,506) | | | | | | — | | | | | | — | | |
養老金結算成本
|
| | | | — | | | | | | — | | | | | | 1,702 | | |
保險結算收益
|
| | | | — | | | | | | — | | | | | | (7,500) | | |
外幣(收益)損失,淨額
|
| | | | (55) | | | | | | (1,054) | | | | | | (113) | | |
清償債務損失
|
| | | | — | | | | | | — | | | | | | 2,598 | | |
調整後的EBITDA-總細分市場
|
| | | $ | 156,489 | | | | | $ | 162,378 | | | | | $ | 149,744 | | |
As of June 30
|
| |
2019
|
| |
2018
|
| ||||||
可識別資產 | | | | | | | | | | | | | |
動物健康
|
| | | $ | 508,864 | | | | | $ | 455,704 | | |
礦質營養
|
| | | | 67,662 | | | | | | 69,779 | | |
性能產品
|
| | | | 32,886 | | | | | | 24,040 | | |
總線段
|
| | | | 609,412 | | | | | | 549,523 | | |
公司
|
| | | | 117,259 | | | | | | 122,156 | | |
總計
|
| | | $ | 726,671 | | | | | $ | 671,679 | | |
As of June 30
|
| |
2019
|
| |
2018
|
| ||||||
財產,廠房和設備,淨額 | | | | | | | | | | | | | |
美國
|
| | | $ | 54,999 | | | | | $ | 55,268 | | |
以色列
|
| | | | 52,434 | | | | | | 45,055 | | |
巴西
|
| | | | 19,647 | | | | | | 19,653 | | |
其他
|
| | | | 13,155 | | | | | | 10,132 | | |
| | | | $ | 140,235 | | | | | $ | 130,108 | | |
| | | | 菲布羅動物衞生公司 | | |||
| August 27, 2019 | | | 依據: | | |
/s/Jack C.Bendheim
傑克·C·本德海姆
董事長、總裁兼首席執行官 |
|
| | | | 菲布羅動物衞生公司 | | |||
| August 27, 2019 | | | 依據: | | |
/s/Jack C.Bendheim
傑克·C·本德海姆
董事長、總裁兼首席執行官 |
|
| August 27, 2019 | | | 依據: | | |
/s/Richard G.Johnson
理查德·G·約翰遜
首席財務官 |
|
| August 27, 2019 | | | 依據: | | |
/s/Daniel M.Bendheim
丹尼爾·M·本德海姆
董事兼執行副總裁, 企業戰略 |
|
| August 27, 2019 | | | 依據: | | |
/s/Jonathan Bendheim
喬納森本海姆(Jonathan Bendheim)
馬奇地區董事兼總裁兼以色列業務部總經理 |
|
| August 27, 2019 | | | 依據: | | |
/s/傑拉爾德·K·卡爾森(Gerald K.Carlson)
傑拉爾德·K·卡爾森
主任 |
|
| August 27, 2019 | | | 依據: | | |
/s/E.Thomas Corcoran
E.託馬斯·科克倫(E.Thomas Corcoran)
主任 |
|
| August 27, 2019 | | | 依據: | | |
/s/Sam Gejdenon
Sam Gejdenon
主任 |
|
| August 27, 2019 | | | 依據: | | |
/s/George Gunn
喬治·岡恩(George Gunn)
主任 |
|
| August 27, 2019 | | | 依據: | | |
/s/Mary Lou Malanoski
瑪麗·盧·馬拉諾斯基
主任 |
|
| August 27, 2019 | | | 依據: | | |
/s/Carol A.Wrenn
Carol A.Wrenn
主任 |
|
| Exhibit 2.1* | | | MVP Laboratory,Inc.、Mary Lou Chapek、AVP、LLC和Phibro Animal Health Corporation之間簽訂的2016年1月12日的資產購買協議(通過引用Phibro Animal Health Corporation於2016年5月9日提交的Form 10-Q季度報告的附件2.1合併)。 | |
| Exhibit 3.1 | | | 修改和恢復菲布羅動物健康公司的公司註冊證書(通過引用Phibro動物健康公司於2014年5月13日提交的10-Q表格季度報告的附件3.1併入(文件號:·001-36410)。 | |
| Exhibit 3.2 | | | 修改和恢復菲布羅動物衞生公司的章程(參照菲布羅動物健康公司於2014年5月13日提交的10-Q表格季度報告的附件3.2合併(文件號001-36410)。 | |
| Exhibit 4.1 | | | Phibro Animal Health Corporation與BFI Co.,LLC之間的註冊權協議,截至2014年4月16日(通過引用Phibro Animal Health Corporation於2014年3月提交的表格S-1/A的註冊聲明中的附件4.9(文件號:333-194467)合併)。 | |
| Exhibit 4.2 | | | 根據1934年“證券交易法”第12節登記的證券描述。 | |
| Exhibit 10.1 | | | Phibro Animal Health Corporation,Bank of America,N.A.與每家貸款人之間於2017年6月29日簽訂的信貸協議(參照Phibro Animal Health Corporation於2017年6月29日提交給證券交易委員會的Form 8-K當前報告的附件10.1合併)。 (文件編號001-36410)。 (*)* | |
| Exhibit 10.2 | | | 無保護租賃協議,日期為2011年1月26日,由撒瑪利亞地毯有限公司和ABIC生物實驗室有限公司達成(翻譯自希伯來語)(參照菲布羅動物衞生公司2014年3月10日提交的表格S-1註冊聲明的附件10.17(文件編號333-194467)合併)。 | |
| Exhibit 10.3 | | | 2014年3月27日簽訂的僱傭協議,由Jack C.Bendheim和Phibro Animal Health Corporation(通過引用Phibro Animal Health Corporation於2014年3月31日提交的表格S-1/A的註冊聲明的附件10.18(文件編號:333-194467)合併)。 | |
| Exhibit 10.4 | | | 2008年5月2日拉里·L·米勒和菲布羅動物健康公司之間的就業邀請函,包括截至2008年5月2日的保密和保密、員工發明以及不競爭和非招標協議(通過引用2014年3月10日提交的菲布羅動物健康公司表格S-1註冊聲明的附件10.20(文件編號:333-194467)合併)。 (*)* | |
| Exhibit 10.5 | | | 澄清僱傭要約修正案,日期為2009年12月21日,由Larry L.Miller和Phibro Animal Health Corporation(通過引用Phibro Animal Health Corporation於2014年3月提交的表格S-1註冊聲明的附件10.21(文件編號:333-194467)合併)。 | |
| Exhibit 10.6 | | | 2011年12月15日拉里·L·米勒和菲布羅動物健康公司之間的就業邀請函修正案(通過引用菲布羅動物健康公司2014年3月10日提交的表格S-1的註冊聲明(文件編號333-194467)的附件10.22合併)。 | |
| Exhibit 10.7 | | | Phibro Animal Health Corporation 2008年激勵計劃(參照Phibro Animal Health Corporation於2014年3月10日提交的表格S-1註冊聲明的附件10.23(文件號:333-194467)合併)。 | |
| Exhibit 10.8 | | | 菲布羅動物健康公司管理激勵計劃(參照2014年3月31日提交的表S-1/A(文件編號:333-194467)的菲布羅動物健康公司註冊聲明的附件10.24併入)。 | |
| Exhibit 10.9 | | | 菲布羅動物健康公司退休收入和遞延補償計劃,截至2009年4月15日修訂和重述(通過引用2014年3月10日提交的表S-1的菲布羅動物健康公司註冊聲明的附件10.25(文件編號:333-194467)併入)。 (*)* | |
| Exhibit 10.10 | | | Phibro Animal Health Corporation執行收入遞延補償協議,日期為1990年3月1日(參照Phibro Animal Health Corporation於2014年3月10日提交的表格S-1的註冊聲明中的附件10.26合併)(文件編號333-194467)。 | |
| Exhibit 10.11 | | | 2009年股票期權授予協議表格(參照菲布羅動物衞生公司2014年3月提交的表格S-1/A的登記聲明(文件編號:333-194467)的附件10.28合併)。 | |
| Exhibit 10.12 | | | 2013年股票期權授予協議表格(參照2014年3月31日提交的Phibro Animal Health Corporation關於表格S-1/A的登記聲明(文件編號333-194467)的附件10.29併入)。 | |
| Exhibit 10.13 | | | 賠償協議表(參照Phibro Animal Health Corporation於2014年4月提交的表S-1/A的註冊聲明的附件10.32合併(文件號333-194467)。 | |
| Exhibit 10.14* | | | MJ Biologics,Inc.於2015年1月20日簽署的知識產權購買協議,以及MJ Biologics,Inc.之間的知識產權購買協議和Phibro Animal Health Corporation(通過引用Phibro Animal Health Corporation的季度報告Form 10-Q(2015年5月11日提交給證券交易委員會)的附件10.33合併) | |
| Exhibit 10.15* | | | MJ Biologics,Inc.於2015年1月20日起草的知識產權購買協議的第一修正案於2018年7月31日生效。和Phibro Animal Health Corporation(通過引用Phibro Animal Health Corporation的季度報告Form 10-Q(2018年11月6日提交給證券交易委員會)的附件10.18合併)。 | |
| Exhibit 10.16 | | | Phibro Animal Health Corporation與Dean J.Warras於2016年6月16日簽署的推廣信協議(通過引用Phibro Animal Health Corporation於2017年8月30日提交給證券交易委員會的Form 10-K 2017年年度報告的附件10.38併入本文(文件號:NO.001-36410)。(*) | |
| Exhibit 10.17 | | | Phibro Animal Health Corporation和Dean J.Warras之間的保留信協議,日期為2016年8月1日(通過引用Phibro Animal Health Corporation於2017年8月30日提交給證券交易委員會的Form 10-K的2017年年度報告的附件10.39併入本文)。 (文件號·001-36410)。 | |
| Exhibit 10.18 | | | 限制性股票單位獎勵協議表格(通過參考菲布羅動物健康公司當前報告Form 8-K的附件10.2併入,表格8-K於2018年5月·7日提交給證券交易委員會(文件號:·13-1840497)。 | |
| Exhibit 10.19 | | | 執行長期激勵協議,日期為2015年5月11日,由菲布羅動物健康公司和理查德·G·約翰遜公司和理查德·G·約翰遜公司之間簽訂,日期為2016年8月1日,菲布羅動物健康公司和迪恩·J·瓦拉斯之間的保留信件協議(通過引用附件·10.34併入菲布羅動物健康公司2015年10-K表格年度報告,於2015年9月10日提交給證券交易委員會(文件編號001-36410) ,該協議由Phibro Animal Health Corporation和Richard G.Johnson簽署,日期為2016年8月1日,Phibro Animal Health Corporation和DeanJ.Warras之間的協議(文件編號:001-36410) | |
| Exhibit 10.20 | | | 由Thomas G.Dagger和Phibro Animal Health Corporation簽署,日期為2006年11月3日的僱傭協議。 | |
| Exhibit 10.21 | | | 修訂僱傭協議,日期為2009年11月16日,由Thomas G.Dagger和Phibro Animal Health Corporation共同簽署。 | |
| Exhibit 10.22 | | | 由Thomas G.Dagger和Phibro Animal Health Corporation共同簽署,日期為2011年12月16日的僱傭協議修正案。 | |
| Exhibit 21.1 | | | 菲布羅動物衞生公司子公司名單 | |
| Exhibit 23 | | | 獨立註冊會計師事務所同意 | |
| Exhibit 31.1 | | | 首席執行官-根據2002年Sarbanes-Oxley法案第302節進行認證 | |
| Exhibit 31.2 | | | 首席財務官-根據2002年Sarbanes-Oxley法案第302節進行認證 | |
| Exhibit 32.1** | | | 首席執行官-根據2002年Sarbanes-Oxley法案第906節進行認證 | |
| Exhibit 32.2** | | | 首席財務官-根據2002年Sarbanes-Oxley法案第906節進行認證 | |
|
附件101.INS*
|
| | XBRL實例文檔 | |
|
附件101.SCH*
|
| | XBRL分類擴展架構文檔 | |
|
附件101.CAL*
|
| | XBRL分類擴展計算鏈接庫文檔 | |
|
附件101.DEF*
|
| | XBRL分類擴展定義鏈接庫文檔 | |
|
附件101.LAB*
|
| | XBRL分類擴展標籤鏈接庫文檔 | |
|
附件101.PRE*
|
| | XBRL Taxonomy Extension Presentation Linkbase文檔 | |